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SUMMARY
Misfolded proteins are often cytotoxic, unless
cellular systems prevent their accumulation. Data
presented here uncover a mechanism by which de-
fects in secretory proteins lead to a dramatic reduc-
tion in their mRNAs and protein expression. When
mutant signal sequences fail to bind to the signal
recognition particle (SRP) at the ribosome exit site,
the nascent chain instead contacts Argonaute2
(Ago2), and the mutant mRNAs are specifically
degraded. Severity of signal sequence mutations
correlated with increased proximity of Ago2 to
nascent chain and mRNA degradation. Ago2 knock-
down inhibited degradation of the mutant mRNA,
while overexpression of Ago2 or knockdown of
SRP54 promoted degradation of secretory protein
mRNA. The results reveal a previously unappreciated
general mechanism of translational quality control, in
which specific mRNA degradation preemptively
regulates aberrant protein production (RAPP).
INTRODUCTION
The cytotoxicity of misfolded and mistargeted proteins is coun-
tered by cellular systems that prevent their accumulation (Stefani
and Dobson, 2003). Cells have strict quality-control systems in
the cytosol and in the endoplasmic reticulum (ER) to distinguish
properly folded proteins from misfolded (Buchberger et al.,
2010; Ellgaard and Helenius, 2003). Secretory and membrane
proteins that are not transported to their proper cellular destina-
tions are either degraded by the ER associated degradation
(ERAD) pathway (Brodsky, 2012; Smith et al., 2011) or form inclu-
sions (Kopito, 2000). When proteins are successfully translo-
cated from the cytosol to the ER, but are not transported further
due to misfolding in stress conditions, the unfolded protein
response (UPR) is activated. UPR involves activation of stress
response genes, general downregulation of protein synthesis,
and degradation of misfolded ER proteins (Schro¨der and Kauf-
man, 2005; Walter and Ron, 2011). Another mechanism that
prevents accumulation of misfolded proteins in the ER during
UPR is regulated ire1-dependent decay (RIDD) (Hollien et al.,
2009; Hollien andWeissman, 2006). This mechanism is activated
under conditions of general ER stress and reduces the quantity
of many mRNAs that encode secretory proteins. Thus, these
processes are general responses to stress conditions and
have not evolved to specifically triage an individual mutant pro-
tein that misfolds. Whether cells can specifically prevent the syn-
thesis of ‘‘unwanted,’’ and potentially hazardous proteins
derived from mutated or foreign mRNAs is only poorly under-
stood. If mutant proteins do not fold properly or fail to be deliv-
ered to the appropriate cellular compartment, they can be
removed by the proteasome system (Ward et al., 1995). Such a
posttranslational mechanism, however, does not prevent
continued de novo production of the mutant gene product.
Currently known systems of mRNA quality control, nonsense
mediated decay (NMD), nonstop decay (NSD), and no-go decay
(NGD), detect only profound defects, including premature stop
codons, lack of a natural stop codon, or stalled ribosomes
(Doma and Parker, 2007; Shoemaker and Green, 2012). These
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structure, but rather, the absence of normal interactions of
nascent chains early in translation.
How does this mechanism discriminate aberrant secretory
proteins with defects in signal sequences from cytosolic proteins
that are not natural substrates for SRP and therefore do not
interact with SRP? In this regard, it is important to note that the
presence of signal sequence is not the only feature that distin-
guishes secretory proteins from cytosolic proteins. The removal
of a signal sequence from a secretory protein will not typically
make it truly cytosolic (having failed translocation, it will be local-
ized to the cytosol, but it will lose its natural binding partners, will
not likely be correctly folded, and will be directed for degrada-
tion), just as adding a signal sequence to a cytosolic protein
will not typically make it truly secretory (although exceptions
are known).
Other factors interact with cytosolic proteins during their
translation. A special network of chaperones linked to protein
synthesis, CLIPS (Albane`se et al., 2006; Pechmann et al.,
2013), and ribosome-associated protein biogenesis factors,
RPBs (Raue et al., 2007), represent the very complex machinery
at the ribosome peptide exit tunnel. Examples include ribosome
associated chaperones Hsp70 SSB (Willmund et al., 2013),
MPP11, and Hsp70L1 (Otto et al., 2005), chaperonin TRiC as
well as numerous others (see for details reviews by Hartl et al.,
2011; Pechmann et al., 2013). Thus, in the case of cytosolic pro-
teins, while their nascent chains do not bind SRP, they interact
with other factors. These interactions may prevent Ago2 associ-
ation and thus would not trigger RAPP.
The crosslinking and functional studies described here impli-
cate Ago2 in the process of specific degradation of mRNAs in
response to synthesis of mutated nascent chains not capable
of efficiently binding SRP. Ago2 is a member of the argonaute
protein family. These proteins are highly conserved and divided
into three subfamilies: Ago-like, PIWI-like, and group 3
(Hutvagner and Simard, 2008; Tolia and Joshua-Tor, 2007).
Mammals contain four Ago-like subfamily members, and Ago2
is the only member known to possess RNA cleavage activity
(Liu et al., 2004; Meister et al., 2004). Historically, and most
commonly known, Ago2 function is associated with noncoding
RNAs (miRNAs or siRNAs) and its participation in formation of
the RNA-induced silencing complex (RISC) responsible for
gene silencing through mRNA cleavage (Hammond et al.,
2001; Martinez et al., 2002). Ago2 has also been reported to
play a key role in translational repression, but by incompletely
understood mechanisms (Djuranovic et al., 2011; Filipowicz
et al., 2008). Recently, Ago2 has been associated with multiple
additional functions in the cell (Meister, 2013). Ago2 is involved
in RNA Interference (RNAi)-mediated regulation of gene expres-
sion, miRNA biogenesis, protection from viruses, transcriptional
regulation, and even alternative splicing (Ameyar-Zazoua et al.,
2012; Cernilogar et al., 2011; Czech and Hannon, 2011;
Djuranovic et al., 2011; Fabian et al., 2010; Filipowicz et al.,
2008; Hutvagner and Simard, 2008). Although many Ago2
functions are most often associated with its ability to bind small
RNAs (Fabian et al., 2010), recent examples indicate that small
RNAs are not involved in all Ago2 functions. A PUF-Ago-eEF1A
complex responsible for attenuation of translational elongation
does not depend on small RNAs (Friend et al., 2012). Ago2
recruitment to chromatin is also RNAi independent (Moshkovich
et al., 2011). Small RNA-independent recruitment to mRNA was
also recently demonstrated for one of two argonautes in
Drosophila (Pinder and Smibert, 2013). The wide variability in
Ago2 reliance on small RNAs andRNase activity may reflectmul-
tiple parallel functions in the cell. Experiments with Ago2 knock
down and its overproduction demonstrated that it is functionally
involved in the RAPP process (Figure 6). Ago2was found in prox-
imity to mutated nascent chains during their synthesis, with
direct correlation between the severity of a mutation in signal
sequence and more efficient crosslinking of the nascent chain
to Ago2 (Figure 5A). Moreover, we have found that mutant pro-
tein mRNA was specifically enriched in Ago2 IP experiments
(Figures 5G, and S4C–S4F). Although questions remain about
whether Ago2 binds mutant mRNA directly, during translation
or at later stages, the data suggest Ago2 is in close proximity
to the mutant nascent chain and mRNA at the same time at the
ribosome. Association of Ago2withmutated nascent chains dur-
ing translation is consistent with earlier observations of Ago2
association with translating ribosomes (Landthaler et al., 2008;
Nelson et al., 2004). It was also shown that Ago2 forms a com-
plex containing L5, L11 ribosomal proteins, along with 5S RNA
(Ishizuka et al., 2002). Experiments with slicer inactive Ago2, as
well as experiments on Dicer and Drosha-knockdowns (Figures
6B and S5) suggest that Ago20s function in RAPP is small RNA-
and slicer-independent.
Although precise role for Ago2, its ability to act as a sensor in
the process, as well as other details of the mechanism remain
obscure, the data presented here indicate that the stability of
mRNA is dictated by the balance of nascent chain interactions
with specific cellular factors at the ribosome exit site, thereby
providing a means to selectively reduce the load of defective
proteins at an early point in translation by specifically degrading
their mRNAs. RAPP provides a mechanism by which defects in
the signal sequence of a secretory protein, or in the secretory
machinery, lead to a dramatic reduction in substrate mRNA
and thus expression of the protein.
EXPERIMENTAL PROCEDURES
Protein translocation was studied using an in vitro translation/translocation
system in the presence of purified canine microsomes or by maturation of
the proteins in human cell culture. Protein visualization in the cells was con-
ducted by immunocytochemistry and confocal microscopy. Cellular mRNA
levels were analyzed by northern blot or qPCR, and proteins by western
blot. For the mRNA stability/degradation experiments, WT and mutant PPLs
cloned under control of the Tet-response element into pTRE2hyg were
expressed in HeLa Tet-Off cells (Clontech) in the presence/absence of doxy-
cycline. SRP54, Ago2, and other protein depletions in human cell culture
were achieved by siRNA technique. Site-specific photocrosslinking using
tRNA-mediated incorporation of a photoreactive probe into a nascent chain
during in vitro translation was conducted as before (Krieg et al., 1986;
McCormick et al., 2003). Method for identification of proteins interacting
with nascent chains employs: (1) in vitro preparation of salt-washed RNCs
containing the photocrosslinking probe in specific position of the nascent
chain; (2) fractionation of the active lysates and assay of fractions containing
the protein of interest using photocrosslinking with salt-washed RNCs; and
(3) identification of proteins in the selected, purified fractions by mass spec-
trometry. SRP and microsomes for in vitro experiments were purified from
canine pancreas. Recombinant human Ago2 was expressed in and purified
from cultured insect cells (Ye et al., 2011).
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quality control mechanisms are not known to involve sensors
that detect misfolded nascent chains or target mRNA templates
whose products are not properly folded/targeted because of
missense mutations.
We hypothesized that when an individual protein misfolds or
fails to be correctly sorted to the appropriate compartment due
to alterations in its protein sequence, processes that specifically
reduce its translation could provide an incisive means of
reducing potential toxicity caused by the accumulation of mis-
folded conformers. Here, we demonstrate the existence
of such amechanism for specificmRNAdegradation in response
to the synthesis of defective proteins.
RESULTS
Mutations in the Signal Sequence of a Secretory Protein
Cause a Defect in Protein Transport and Lead to
Decreased Production of Mutant Proteins
Secretory proteins contain N-terminal signal sequences (von
Heijne, 1983). The signal sequence is cotranslationally recog-
nized by SRP (Walter et al., 1981). The ribosome-nascent
chain-SRP complex is targeted to its receptor in the ER mem-
brane where the nascent chain is translocated into ER lumen
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Figure 1. Deletions in the PPL Signal
Sequence Lead to Defects in Protein Trans-
port and Expression
(A) Signal sequences of WT and mutated PPLs,
deletions indicated by dashes.
(B) WT and mutant PPLs were synthesized in a
rabbit reticulocyte translation system in vitro in the
presence or absence of ER microsomes, analyzed
by SDS-PAGE, and detected by autoradiography.
Positions of mature PPL (m) and precursor (p) are
shown.
(C and D) WT and mutant PPLs were transiently
expressed in HeLa Tet-On cells (cells with empty
vector [V] were controls) and detected by western
blot or by immunofluorescence, respectively.
AcGFP, expressed from the same plasmids, and
endogenous actin were controls.
(E) Effect of the proteasome inhibitor MG132 on
the level of WT and D4L PPLs (detection by
western blot).
(F) Pulse-labeling analysis of translated WT (blue
circles) and D4L (red triangles) PPLs in the pres-
ence (dashed lines, n = 4) and absence (solid lines,
n = 5) of MG132 (mean ±SEM). See also Figure S1.
by the Sec61p/TRAM translocon, and
finally the signal sequence is removed
by signal peptidase (Alder and Johnson,
2004; Egea et al., 2005; Rapoport, 2007;
Wild et al., 2004). Preprolactin (PPL) is a
secretory protein that contains a proto-
typical signal sequence. We constructed
mutant PPLs with deletions within the
signal sequence hydrophobic core (Fig-
ure 1A) and assessed protein transloca-
tion. In vitro translated wild-type (WT)
PPL was efficiently translocated into ER microsomes as
detected by processing of the precursor (signal sequence
cleavage) (Figure 1B). Deletion of leucines from the signal
sequence reduced translocation, with the number of deleted leu-
cines directly correlating with the degree of the transport defect.
WT PPL expressed in cell culture was efficiently secreted,
reflected by the presence of its mature form in the cells and
media (Figure 1C). However, the D3L and D4L mutants did not
mature and their protein levels were dramatically decreased.
The decrease directly correlated with the number of deleted leu-
cines. In contrast to WT PPL, the D4L mutant was not detected
by immunocytochemistry (Figure 1D). Notably, levels of AcGFP
expressed from an independent promoter on the same plasmid,
and of endogenous actin, were not affected (Figures 1C and 1D).
Thus, mutations in the signal sequence lead to specific reduc-
tions in the quantities of the mutant proteins. The simplest expla-
nation is that mutant proteins are degraded by the proteasome.
However, inhibition of the proteasome with MG132 produced
only a marginal change (Figure 1E). Hence, reduction in the level
of the proteins cannot be explained by proteasomal degradation.
Alternatively, the decrease in mutant protein levels could be
caused by a reduction in their translation. Pulse-labeling of WT
and D4L proteins showed that translation of the mutated protein
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We hypothesized that when an individual protein misfolds or
fails to be correctly sorted to the appropriate compartment due
to alterations in its protein sequence, processes that specifically
reduce its translation could provide an incisive means of
reducing potential toxicity caused by the accumulation of mis-
folded conformers. Here, we demonstrate the existence
of such amechanism for specificmRNAdegradation in response
to the synthesis of defective proteins.
RESULTS
Mutations i the Signal Sequence of a Secretory Protein
Cause a Defect in Protein Transport and Lead to
Decreased Pr duction of Mutant Proteins
Secretory protei s contain N-terminal signal sequen es (von
Heijne, 1983). The signal sequence is cotranslationally recog-
nized by SRP (Walt r et al., 1981). The ribosome-nascent
c ain-SRP complex is targeted to its receptor in the ER mem-
brane where the nascent chain is translocated into ER lumen
A B
C
D
E F
Figure 1. Deletions in the PPL Signal
Sequence Lead to Defects in Protein Trans-
port and Expression
(A) Signal sequences of WT and mutated PPLs,
deletions indicated by dashes.
(B) WT and mutant PPLs were synthesized in a
rabbit reticulocyte translation system in vitro in the
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PPL was efficiently translocated into ER microsomes as
detected by processing of the precursor (signal sequence
cleavage) (Figure 1B). Deletion of leucines from the signal
sequence reduced translocation, with the number of deleted leu-
cines directly correlating with the degree of the transport defect.
WT PPL expressed in cell culture was efficiently secreted,
reflected by the presence of its mature form in the cells and
media (Figure 1C). However, the D3L and D4L mutants did not
mature and their protein levels were dramatically decreased.
The decrease directly correlated with the number of deleted leu-
cines. In contrast to WT PPL, the D4L mutant was not detected
by immunocytochemistry (Figure 1D). Notably, levels of AcGFP
expressed from an independent promoter on the same plasmid,
and of endogenous actin, were not affected (Figures 1C and 1D).
Thus, mutations in the signal sequence lead to specific reduc-
tions in the qua tities of the mutant proteins. T e simplest expla-
nation is that mutant proteins re degraded by the proteasome.
However, inhibition of the proteasom with MG132 produced
only a marginal chang (Figur 1E). Hence, reduction in the level
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Figure S1. Translation of Mutated D4L PPL is Impaired, Related to Figure 1
Analysis of translated WT and D4L PPL was done in transiently expressing HeLa Tet-On cells following pulse-labeling with radiolabeled methionine. PPLs were
immunoprecipitated at different times after initiation of the pulse, and then analyzed by SDS-PAGE and autoradiography. Cells were treated with MG132 where
indicated.
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Figure 2. Defects in the Signal Sequence or in a Targeting Factor, SRP, Lead to Decreased Levels of a Secretory Protein mRNA
(A and B) Effect of deletions in signal sequence on PPL mRNA levels. PPL and control mRNAs were analyzed by northern blot (A) or qPCR (B; n = 9, mean ± SD)
42 hr after transfection of HeLa Tet-On with WT and mutated PPL plasmids.
(C) Presence of a mutated PPL signal sequence (PPL-D4L) in hybrid proteins containing the mature part of a1-antitrypsin (AT) or carbonic anhydrase IV (CA4) is
sufficient to trigger mRNA depletion. mRNA levels measured by qPCR (n = 3, mean ± SD) are shown relatively to mRNA levels of corresponding hybrid proteins
containing WT PPL signal sequence (PPL-WT).
(D) Deletions (indicated by dashes) in the natural signal sequences of secretory proteins AT or CA4.
(E) Deletions in the hydrophobic core of natural signal sequences of AT or CA4 proteins lead to a decrease in their mRNA levels. Graph shows mRNA levels
measured by qPCR (n = 3, mean ± SD).
(F) Scheme shows differences in biogenesis of secretory and cytosolic proteins. When the signal sequence of a secretory protein emerges from the ribosomal
tunnel it is recognized by SRP, and the complex is targeted to SRP receptor and finally to a translocon in ER membrane. Nascent chains of cytosolic proteins do
not have signal sequences, however, their nascent chains are recognized by ribosome-associated chaperones and that help them fold in the cytosol.
(G and H) SRP depletion causes a reduction in the level of secretory protein mRNA. Detection of PPL, and actin mRNAs (northern blot), SRP54, PPL and actin
proteins (western blot) in HeLa Tet-On cells transfected with siRNA for SRP54 andWT orD4L PPL plasmids as indicated (G). Quantification ofWT PPL (open bars)
or D4L mutant (black bars) mRNAs by qPCR in independent sets of SRP54 knockdown experiments (n = 3, mean ± SD) (H).
(I) Knockdown of SRP receptor subunits SRa and SRb, or translocon component, Sec61a, does not affect PPL mRNA level (qPCR, n = 3, mean ± SD). WT PPL
(open bars), D4L mutant (black bars).
(legend continued on next page)
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(G and H) SRP depletion causes a reduction in the level of secretory protein mRNA. Detection of PPL, and actin mRNAs (northern blot), SRP54, PPL and actin
proteins (western blot) in HeLa Tet-On cells transfected with siRNA for SRP54 andWT orD4L PPL plasmids as indicated (G). Quantification ofWT PPL (open bars)
or D4L mutant (black bars) mRNAs by qPCR in independent sets of SRP54 knockdown experiments (n = 3, mean ± SD) (H).
(I) Knockdown of SRP receptor subunits SRa and SRb, or translocon component, Sec61a, does not affect PPL mRNA level (qPCR, n = 3, mean ± SD). WT PPL
(open bars), D4L mutant (black bars).
(legend continued on next page)
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was dramatically impaired while turnover was not affected (Fig-
ures 1F and S1 available online), suggesting that the lower
level of mutant translation may be caused by reduction in
mutant mRNA.
Deletions in the Signal Sequence of Secretory Proteins
Cause a Reduction in Their mRNA Levels
Using two independent techniques, northern blot and quantita-
tive real-time PCR (qPCR), we found that levels of PPL mRNA
decreased as the number of deleted leucines in the signal
sequence increased (Figures 2A and 2B). This effect was specific
for mutant PPLs, as neither AcGFP nor actin mRNAs levels
changed (Figure 2A). The same effect was observed in two other
cell lines (Figure S2), indicating that the process of mutant mRNA
elimination is independent of the cell type. We also constructed
hybrid proteins containing WT PPL or mutated PPL D4L signal
sequences fused to mature sequences of two other secretory
proteins, a1-antitrypsin (AT) or carbonic anhydrase IV (CA4),
and measured their mRNA levels (Figure 2C). The mRNA levels
of the hybrid proteins with mutated signal sequences were
reduced, indicating that the presence of aberrant signal
sequence was sufficient to trigger mRNA depletion regardless
of the sequence of the mature secretory protein. These data
suggested the existence of a specific mechanism for decreasing
mutant mRNA levels.
To establish generality of themechanismwemade deletions in
the natural signal sequences of AT and CA4 and found that their
mRNA levels were also reduced (Figures 2D–2E), similar to the
reductions of mRNA levels of mutated PPL and hybrid proteins
(Figures 2B–2C). These results indicate that the effect of mRNA
reduction is determined by the defects in the translated signal
sequences independently of their amino acid sequences,
making the scenario of reduction of mRNA levels due to changes
in mRNA secondary structure unlikely. These data demonstrate
that the mRNA-depletion mechanism is general and selective.
SRP Depletion Leads to a Decrease in the mRNA Levels
of Secretory Proteins
Secretory and cytosolic proteins have different biogenesis path-
ways.While cytosolic proteins require different ribosome associ-
ated chaperones and chaperonins for their proper folding in the
cytoplasm, for a secretory protein, the first step in protein trans-
port is recognition of its signal sequenc by SRP and formation
of the SRP-RNC (ribosome- ascent chain) complex (Figure 2F).
Since mRNA levels were reduced by mutations that were pre-
dicted to alter signal sequence-SRP interactions, the role of
SRP in the mRNA quality control process was independently
evaluated by decreasing its intracellular concentration. siRNA
was used to efficiently decr ase SRP i human c ll culture.
SRP epletion caused a dramatic reduction in mRNA levels (as
detected by northern blot and qPCR) and protein levels of both
WT and mutant PPLs (Figures 2G–2H). In the next step of bio-
genesis the SRP-RNC complex is targeted to the SRP receptor
at the ERmembrane, then the RNC is transferred to a translocon
and the nascent chain is cotranslationally translocated into the
ER lumen, where it is folded with the help of ER chaperones (Fig-
ure 2F). Contrary to SRP depletion, no effect on WT or D4L
mRNA was found when SRP receptor subunits SRa and SRb
or the core component of the translocon, Sec61a, were depleted
(Figure 2I). The data clearly demonstrate that mRNA depletion of
a secretory protein occurs when its nascent chain loses
interaction with SRP, suggesting that selection of mRNA for
degradation takes place at the ribosome during translation,
when the N-terminal portion of a mutated nascent chain exits
the ribosomal tunnel but is not recognized by SRP.
To address the fate of mRNAs of other potential substrates for
SRP, endogenous mRNA levels of secretory and ER resident
proteins were measured in SRP depleted cells. mRNA levels of
the secretory proteins alkaline phosphatase, as well as ER local-
ized proteins Bip and calreticulin, were dramatically reduced in
SRP54 depleted cells (Figure 2J). All of these proteins have
signal sequences and are transported from the cytosol. By
contrast, mRNA levels of the nonsecreted cytosolic protein
hypoxanthine phosphoribosyltransferase (HPRT) and the SRP-
independent ER membrane-associated protein SRa (Andrews
et al., 1989; Lakkaraju et al., 2007) were not affected (Figure 2J).
The data demonstrate that the loss of targeting factor SRP leads
to specific elimination of the mRNAs coding for its substrates.
Thus, mRNA depletion correlates with an abnormality in the
signal sequence recognition process, including either a muta-
tion in the signal sequence or a decrease in the amount of func-
tional SRP.
Decrease in mRNA Level Is Due to mRNA Degradation
Reduction of steady state mRNA levels could be achieved by
either reducing transcription or increasing mRNA degradation.
To test whether mutant mRNA degradation was increased,
mRNA levels were monitored as a function of time after tran-
scriptional inhibition (Figure 3A). WT and mutant PPL were
cloned into the pTRE2hyg vector. This vector contains the induc-
ible Tet-response element and aminimal CMV promoter. In HeLa
Tet-Off cells cultured in the absence of the antibiotic, the mRNA
is transcribed normally, while the addition of doxycycline inhibits
transcription. Doxycycline was added 20 hr after transfection to
ensure that adequate levels of D4L mRNA still remained at the
start of the experiment (Figure 3A, inset). The turnover of WT
PPL mRNA (observed by qPCR) as a function of time in doxycy-
cline-treated (versus untreated) cells indicates the normal rate of
mRNA degradation (Figure 3A). The D4L PPL mRNA turned over
significantly faster than WT PPL mRNA, indicating that the
mutant mRNA was preferentially degraded.
The Mechanism Discriminates Muta t from Wild-Type
mRNAs
To determine whether the mutant protein induces a general
cellular response that acts on both mRNAs or acts specifically
(J) SRP depletion causes reduction in endogenous mRNA levels of secretory and ER proteins. Measured by qPCR (n = 3, mean ± SD) mRNA levels in SRP
depleted cells are shown relatively those treated with control siRNA (taken as 1). Intestinal alkaline phosphatase (AP) is a secretory protein, Bip and calreticulin
(Calr) are ER lumen proteins. mRNA levels of the cytosolic protein HPRT and the SRP-independent ER membrane-associated protein SRa were not altered.
See also Figure S2 and Table S1.
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Figure S2. Effect of D4L in PPL Signal Sequence on PPL mRNA Levels in Transiently Transfected HEK293 or HeLa, Related to Figure 2
(A and B) PPL mRNAs were analyzed by qPCR for HEK293 (A) or HeLa (B).
Cell 156, 146–157, January 16, 2014 ª2014 Elsevier Inc. S7
on themutantmRNA,WT andD4L PPLswere coexpressed. Pro-
tein levels were detected by western blotting (Figure S3) and
mRNA levels were determined by qPCR using primers to detect
both WT and D4L, or specifically the WT or the mutant (Figures
3B–3D). The total amount of PPL message in cells coexpressing
mutant and WT was equivalent to the sum of the two mRNAs
expressed independently. Thus, the presence of WT protein
and mRNA did not prevent degradation of mutant mRNA (Fig-
ure 3D), nor did the presence of mutant mRNA lead to increased
degradation of WT mRNA (Figure 3C). These data indicate that
the cellular machinery discriminates between WT and mutant
mRNAs and specifically targets mutant mRNA for degradation.
A Functional Signal Sequence Protects mRNA of a
Secretory Protein from Degradation
The results of the SRP knockdown experiment on endogenous
transcripts suggest that the mechanism does not involve direct
recognition of the abnormal mutant mRNA structures or
sequences. Instead, the data suggest a link between the trans-
lation of abnormal proteins and the degradation of their mRNA.
To directly test this hypothesis, PPL constructs were analyzed
that contained a deletion of one, two, or three nucleotides at
the beginning of the signal sequence to create either frame-shifts
in the open reading frame or the deletion of a codon (Figure 4A).
The deletions of one or two nucleotides led to dramatic changes
in the protein sequence because of a frame shift in the reading
frame and onlyminor changes (removing one or two nucleotides)
in mRNA. By contrast, the deletion of three nucleotides leads to
larger changes in mRNA and smaller changes (deletion of one
residue) in the protein. As predicted, the mRNA levels of
frame-shift mutants were depressed, while the level of mRNA
with a deleted codon was not affected (Figures 4B–4C). These
results indicate that the translation of the native nascent chain
is important. To localize the sequence that is important for pro-
tection of mRNA from degradation, additional nucleotide(s)
were introduced into frame-shift mutants to restore the PPL
reading frame after the signal sequence (Figure 4A). The resul-
tant nascent chains contained dramatic changes in the signal
sequence, but no changes in the mature protein. The levels of
these mRNAs were low (Figures 4B–4C). These results sug-
gested that the signal sequence protects secretory protein’s
mRNA from degradation. To test this hypothesis we prepared
a PPL construct without a signal sequence, PPL-DSS, and found
that its mRNA level was decreased (Figure 4D). Similar results
were obtained using two other secretory proteins, AT and CA4
lacking signal sequences (Figure 4D). All data together demon-
strate that the presence of a functional signal sequence in the
nascent chain is important for protection of the mRNA from
degradation.
Presence of a Mutant Signal Sequence in Hybrid
Cytosolic Proteins Leads to Their mRNA Depletion
While the lack of a functional signal sequence in secretory pro-
teins leads to significant decrease of their mRNA levels, the
mRNAs of cytosolic proteins are stable despite the fact that
they do not have signal sequences. The biogenesis of cytosolic
proteins is significantly different from that of secretory proteins
(Figure 2F). During de novo synthesis of cytosolic proteins,
A
B
C
D
Figure 3. Preferential Degradation of Mutant PPL mRNA
(A) qPCR analysis of WT (blue circles) or D4L (red triangles) PPL
mRNAs under conditions of transcription inhibition (doxycycline treat-
ment, dashed lines and open symbols) or mock (solid lines and symbols).
Doxycycline was added 20 hr after transfection to ensure that ade-
quate levels of D4L mRNA still remained at the start of the experiment;
the initial WT and D4L mutant mRNA content was about 2:1 (inset). The
quantity of mRNA at each time point is shown relative to the initial
quantity of the respective mRNA species. Data are from three experi-
ments, where each time point contained three repeats in each experiment
(mean ± SD).
(B to D) qPCR analysis (n = 5, mean ± SD) of PPL WT and D4L mRNAs using
primers amplifying both WT and mutant (B), only WT (C), or only D4L (D) in the
cultured human cells expressing WT PPL only (WT), D4L mutant only (D4L),
bothWT andD4L (WT+D4L), or transfectedwith empty vector (V). mRNA levels
are shown relative to WT, except in (D), where mRNA levels were scaled to
equate the D4L level in (D) to that in (B).
See also Figure S3.
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on themutantmRNA,WT andD4L PPLswere coexpressed. Pro-
tein levels were detected by western blotting (Figure S3) and
mRNA levels were determined by qPCR using primers to detect
both WT and D4L, or specifically the WT or the mutant (Figures
3B–3D). The total amount of PPL message in cells coexpressing
mutant and WT was equivalent to the sum of the two mRNAs
expressed independently. Thus, the presence of WT protein
and mRNA did not prevent degradation of mutant mRNA (Fig-
ure 3D), nor did the presence of mutant mRNA lead to increased
degradation of WT mRNA (Figure 3C). These data indicate that
the cellular machinery discriminates between WT and mutant
mRNAs and specifically targets mutant mRNA for degradation.
A Functional Signal Sequence Protects mRNA of a
Secretory Protein from Degradation
The results of the SRP knockdown experiment on endogenous
transcripts suggest that the mechanism does not involve direct
recognition of the abnormal mutant mRNA structures or
sequences. Instead, the data suggest a link between the trans-
lation of abnormal proteins and the degradation of their mRNA.
To directly test this hypothesis, PPL constructs were analyzed
that contained a deletion of one, two, or three nucleotides at
the beginning of the signal sequence to create either frame-shifts
in the open reading frame or the deletion of a codon (Figure 4A).
The deletions of one or two nucleotides led to dramatic changes
in the protein sequence because of a frame shift in the reading
frame and onlyminor changes (removing one or two nucleotides)
in mRNA. By contrast, the deletion of three nucleotides leads to
larger changes in mRNA and smaller changes (deletion of one
residue) in the protein. As predicted, the mRNA levels of
frame-shift mutants were depressed, while the level of mRNA
with a deleted codon was not affected (Figures 4B–4C). These
results indicate that the translation of the native nascent chain
is important. To localize the sequence that is important for pro-
tection of mRNA from degradation, additional nucleotide(s)
were introduced into frame-shift mutants to restore the PPL
reading frame after the signal sequence (Figure 4A). The resul-
tant nascent chains contained dramatic changes in the signal
sequence, but no changes in the mature protein. The levels of
these mRNAs were low (Figures 4B–4C). These results sug-
gested that the signal sequence protects secretory protein’s
mRNA from degradation. To test this hypothesis we prepared
a PPL construct without a signal sequence, PPL-DSS, and found
that its mRNA level was decreased (Figure 4D). Similar results
were obtained using two other secretory proteins, AT and CA4
lacking signal sequences (Figure 4D). All data together demon-
strate that the presence of a functional signal sequence in the
nascent chain is important for protection of the mRNA from
degradation.
Presence of a Mutant Signal Sequence in Hybrid
Cytosolic Proteins Leads to Their mRNA Depletion
While the lack of a functional signal sequence in secretory pro-
teins leads to significant decrease of their mRNA levels, the
mRNAs of cytosolic proteins are stable despite the fact that
they do not have signal sequences. The biogenesis of cytosolic
proteins is significantly different from that of secretory proteins
(Figure 2F). During de novo synthesis of cytosolic proteins,
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(A) qPCR a alysis of WT (blue circles) or D4L (red triangles) PPL
mRNAs un er conditions of ranscription inhibition (doxycycline treat-
ment, dashed lines and open symbols) or mock (solid lines and symbols).
Doxycycline was added 20 hr after transfection to ensure that ade-
quate levels of D4L mRNA still remained at the start of the experiment;
the initial WT and D4L mutant mRNA content was about 2:1 (inset). The
quantity of mRNA at each time point is shown relative to the initial
quantity of the respective mRNA species. Data are from three experi-
ments, where each time point contained three repeats in each experiment
(mean ± SD).
(B to D) qPCR analysi ( = 5, mean ± SD) of PPL WT and D4L mRNAs using
primers amplifying both WT and mutant (B), only WT (C), or only D4L (D) in the
cultured human cells expressing WT PPL only (WT), D4L mutant only (D4L),
bothWT andD4L (WT+D4L), or transfectedwith empty vector (V). mRNA levels
are shown relative to WT, except in (D), where mRNA levels were scaled to
equate he D4L lev l in (D) to that in (B).
See also Figure S3.
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Figure S3. Western Blot Analysis of PPL in HeLa Tet-On Cells Expressing WT PPL, D4L Mutant, Both WT and D4L, Related to Figure 3
V is an empty vector control and AcGFP and actin were transfection and loading controls.
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nascent chains interact with a set of ribosome associated chap-
erones linked to protein synthesis (CLIPS) (Albane`se et al., 2006;
Pechmann et al., 2013) or ribosome-associated protein biogen-
esis factors (RPBs) (Raue et al., 2007). Although a sequence
consensus for interaction with ribosome bound chaperones
has not been reported for cytosolic proteins, it is known that
the affinities of ribosome bound chaperones, as well as posi-
tioning of nascent chains, are influenced by the amino acid
sequence of the nascent polypeptide (Raue et al., 2007). Thus,
the N-terminal sequence of nascent chains is likely responsible
for specificity of these interactions.
Hybrids of cytosolic proteins luciferase (Luc) or pyruvate
kinase (PK) containing WT or D4L PPL signal sequences at their
N termini were prepared. While the WT signal sequence did not
lead to mRNA depletion of a hybrid protein, the presence of the
mutant D4L signal sequence led to a significant decrease of
mRNAs for both tested hybrid proteins, PK and luciferase
(Figure 4E). The presence of aWT signal sequencemay not influ-
ence the mRNA level because it is recognized by SRP, and thus
the mRNA remains protected. However, an aberrant signal
sequence will not be recognized by SRP, nor by normal cytosolic
protein partners at the ribosome. This observation indicates that
the selection of the mRNA for degradation is conducted at a very
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Figure 4. Functional Signal Sequence is
Required for Protection of the Secretory
Protein mRNA from Degradation
(A) N-terminal sequences of PPL mutants with
amino acid substitutions in bold and underlined,
and deletions as dashes. FS(!1), FS(!2), FS(!3)
contain deletions of one, two, three nucleotides,
correspondingly, in the third codon. FS(!1, +1),
FS(!2,+2) contain additional insertion of one or
two nucleotides in the codon 29 to restore original
reading frame. mRNAs were analyzed by northern
blots (B) or by qPCR (C; n = 3, mean ± SD).
(D) Deletions of natural signal sequences from
PPL, AT, and CA4 lead to decrease in their mRNA
levels (qPCR, n = 3, mean ± SD).
(E) Presence of a mutated signal sequence in
hybrid cytosolic proteins leads to their mRNA
depletion (qPCR, n = 3, mean ± SD).
early step in translation, when the N-ter-
minal sequence of a nascent chain first
appears from the ribosomal tunnel. The
experiments clearly demonstrate that
cellular quality control machinery can
distinguish between nascent chains of a
normal cytosolic protein and a hybrid
containing mutated signal sequence.
Mutation of the PPL Signal
Sequence Shifts its Interaction
from SRP to a "100 kDa Protein
We hypothesized that mutations in the
nascent chain might lead to the recruit-
ment of specific interacting factors at
the ribosome exit site during translation
that trigger mRNA degradation. Site-specific photocrosslinking
(Krieg et al., 1986; McCormick et al., 2003) has been employed
to study the interactions of a nascent chain with cellular fac-
tors. This approach is based on the tRNA-mediated incorpora-
tion of a photoreactive probe into a nascent chain at a specific
position(s) during in vitro translation (Figure S4A). Radiolabeled
ribosome-nascent chain complexes (RNCs) of WT and mutant
PPLs were synthesized in vitro in the presence of SRP using
mRNAs truncated after codon 86, so only a short portion of
the nascent chain, including the signal sequence, was exposed
outside the ribosome. The photoreactive probe was positioned
in the middle of the signal sequence. When exposed to UV
light, the photoprobes form covalent bonds with molecules in
close proximity, and the resulting photoadducts are detected
by a shift in nascent chain electrophoretic mobility (Figure S4B).
WT PPL forms a photoadduct with a "50 kDa protein (Fig-
ure 5A) that was confirmed by immunoprecipitation to be the
SRP54 subunit of SRP (Figure 5B). Deletion of leucines in the
mutant PPL decreased the efficiency of photocrosslinking to
SRP54 while simultaneously increasing the efficiency of forma-
tion of a photoadduct with a "100 kDa protein (Figure 5A).
Consistent with the SRP knockdown experiment (Figures 2G–
2H), the adduct to the "100 kDa protein was also formed
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nascent chains inte act with a set of ribosom sociated chap-
erones linked to protein synthesis (CLIPS) (Albane`se et al., 2006;
Pechmann et al., 2013) or ribosome-associated protein biogen-
esis factors (RPBs) (Raue et al., 2007). Although a sequence
consensus for interaction with ribosome bound chaperone
has not been reported for cytosolic proteins, it is known that
the affinities of ribosome bound chaperones, as well as posi-
tioning of nascent hains, are influenced by the amino acid
sequence of the nasce t polypeptide (Raue et al., 2007). Thus,
the N-terminal sequence of nascent chains is likely responsible
for specificity of these interactions.
Hybrids of cytosolic proteins luciferase (Luc) or pyruvate
kinase (PK) containing WT or D4L PPL signal sequences at their
N termini were prepared. While the WT signal sequence did not
lead to mRNA depletion of a hybrid protein, the presence of the
mutant D4L signal sequence led to a significant decrease of
mRNAs for both tested hybrid proteins, PK and luciferase
(Figure 4E). The presence of aWT signal sequencemay not influ-
ence the mRNA level because it is recognized by SRP, and thus
the mRNA remains protected. However, an aberrant signal
sequence will not be recognized by SRP, nor by normal cytosolic
protein partners at the ribosome. This observation indicates that
the selection of the mRNA for degradation is conducted at a very
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Required for Protection of the Secretory
Protein mRNA from Degradation
(A) N-terminal sequences of PPL mutants with
amino acid substitutions in bold and underlined,
and deletions as dashes. FS(!1), FS(!2), FS(!3)
contain deletions of one, two, three nucleotides,
correspondingly, in the third codon. FS(!1, +1),
FS(!2,+2) contain additional insertion of one or
two nucleotides in th codon 29 to restore original
reading fra e. mRNAs were analyzed by northern
blots (B) or by qPCR (C; n = 3, mean ± SD).
(D) Deletions of natural signal sequences from
PPL, AT, and CA4 lead to decrease in their mRNA
levels (qPCR, n = 3, mean ± SD).
(E) Presence of a mutated signal sequence in
hybrid cytosolic proteins leads to their mRNA
d pl tion (qPCR, n = 3, mean ± SD).
early step in translation, when the N-ter-
minal sequence of a nascent chain first
appears from the ribosomal tunnel. The
experiments clearly demonstrate that
cellular quality control machinery can
distinguis b tween nascent chains of a
normal ytosolic protein and a hybrid
containing mutated signal sequence.
Mutation of the PPL Signal
Sequence Shifts its Interaction
from SRP to a "100 kDa Protein
W hypothesized that mutations in the
nascent chai might lead to the recruit-
ment of specific interacting factors at
the ribosome exit site during translation
that trigger mRNA degradation. Site-specific photocrosslinking
(Krieg et al., 1986; McCormick et al., 2003) has been employed
to study the interactions of a nascent chain with cellular fac-
tors. This approach is based on the tRNA-mediated incorpora-
tion of a photoreactive probe into a n scent chain at a specific
position(s) during in vitro translation (Figure S4A). Radiolabeled
ribosome-nascent chain complexes (RNCs) of WT and mutant
PPLs were synthesized in vitro in th presence of SRP using
mRNAs truncated after c don 86, so only a short portion of
the nascent chain, including the signal sequence, was exposed
outside the ribosome. The photoreactive probe was positioned
in the middle of the signal sequence. When exposed to UV
light, the photoprobes form covalent bonds with molecules in
close proximity, and the resulting photoadducts are detected
by a shift in nascent chain electrophoretic mobility (Figure S4B).
WT PPL forms a photoadduct with a "50 kDa protein (Fig-
ure 5A) that was confirmed by immunoprecipitation to be the
SRP54 subunit of SRP (Figure 5B). Deletion of leucines in the
mutant PPL decreased the efficiency of photocrosslinking to
SRP54 while simultaneously increasing the efficiency of forma-
tion of a photoadduct with a "100 kDa protein (Figure 5A).
Consistent with the SRP knockdown experiment (Figures 2G–
2H), the adduct to the "100 kDa protein was also formed
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with WT PPL when the reaction was not supplemented with
SRP (Figure 5C). This behavior implicated the !100 kDa pro-
tein in the initial step of the process that leads to the specific
degradation of mutant PPL mRNA or WT PPL mRNA when
SRP is limiting.
Argonaute2 is in Close Proximity to Mutant Nascent
Chains during Translation and Associates with
Mutant mRNA
To identify proteins interacting with nascent chains we combined
site-specific photocrosslinking with protein fractionation and
mass spectrometry. This allowed identification of proteins
involved in short-lived, transient interactions during translation.
The approach includes: in vitro preparation of salt-washed
RNC complexes with an incorporated photocrosslinking probe,
by the use of modified amber-suppressor tRNA (salt-washing
removes ribosome-associated proteins); fractionation of cellular
proteins, and selection of fractions containing the protein of
interest using the photocrosslinking assay; and identification of
proteins in the selected fractions by mass spectrometry (Fig-
ure 5D). This method for identification of proteins interacting
with nascent chains (iPINCH) is a valuable tool for identification
of partners in transient protein-protein interactions during
translation.
RNCs of D4L PPL containing the photocrosslinking probe
were prepared in an in vitro translation system. As expected
the nascent chain of the mutated protein photocrosslinked
the !100K protein (Figure 5E, lane RNC). Washing the RNCs
with high-salt buffer removed most of the !100 kDa protein,
but upon adding lysate back to salt-washed RNCs, photocros-
slinking to the !100 kDa protein was reconstituted (Figure 5E,
lane ‘‘Lysate’’). A crude reticulocyte preparation of ribosome-
associated proteins, which restored photoadduct formation,
was fractionated and fractions containing the protein of interest
were identified (Figure 5E, fractions 8–10). Analysis by mass
spectroscopy revealed that the protein was Argonaute2
(Ago2) (Table S2). Ago2, a member of the argonaute protein
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Figure 5. Ago2 is in Close Proximity to Mutant Nascent Chains and
Associated with Mutant mRNA
(A) Deletions in the PPL signal sequence lead to reduced interaction with
SRP54 and increased proximity to a !100 kDa protein. Photocrosslinking
patterns of WT and mutated PPLs are shown. RNCs containing the first 86
residues of WT and mutant PPLs with a photoreactive probe in the signal
sequence were produced in vitro in the presence of SRP. Following UV irra-
diation, samples were analyzed by electrophoresis and autoradiography. The
positions of photoadducts containing !50 kDa (circle) or !100 kDa (diamond)
proteins are shown.
(B) Immunoprecipitation (IP) using SRP54 specific antibody demonstrates that
the !50 kDa protein is SRP54.
(C) WT PPL crosslinks to the !100 kDa protein are maximized when lysate is
not supplemented with SRP.
(D) Scheme of the method for identification of proteins interacting with nascent
chains (iPINCH).
(E) Identification of fractions that contain the !100 kDa protein. D4L RNCs
were prepared as above and treated with a high-salt buffer. The latter were
combined with lysate or aliquots of fractionated rabbit reticulocyte ribosome-
associated proteins, incubated, UV irradiated and analyzed as in A. The
photocrosslinking pattern of the fraction examined by mass spectrometry is
boxed.
(F) Recombinant Ago2 is in close proximity to mutant nascent chain. Purified
recombinant human Ago2 or buffer was added to salt-washed RNCs of D4L
PPL mutant with photocrosslinking probe. Samples were photocrosslinked
and analyzed as above.
(G) mRNA of D4L PPL is preferentially enriched in Ago2 immunoprecipitates. A
short incubation time (20–24 hr after plasmid transfection) was used to ensure
that significant levels ofD4LmRNA still remained at the start of the experiment:
the WT and D4L mutant mRNA content in cell lysates was about 2:1 before IP
(inset). Mouse monoclonal Ago2 antibody was used for IP. Data are from two
qPCRs, reactions were in triplicates, mean ± SD.
See also Figure S4 and Table S2.
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with WT PPL when the reaction was not supplemented with
SRP (Figure 5C). This behavior implicated the !100 kDa pro-
tein in the initial step of the process that leads to the specific
degradation of mutant PPL mRNA or WT PPL mRNA when
SRP is limiting.
Argonaute2 is in Close Proximity to Mutant Nascent
Chains during Translation and Associates with
Mutant mRNA
To identify proteins interacting with nascent chains we combined
site-specific photocrosslinking with protein fractionation and
mass spectrometry. This allowed identification of proteins
involved in short-lived, transient interactions during translation.
The approach includes: in vitro preparation of salt-washed
RNC complexes with an incorporated photocrosslinking probe,
by the use of modified amber-suppressor tRNA (salt-washing
removes ribosome-associated proteins); fractionation of cellular
proteins, and selection of fractions containing the protein of
interest using the photocrosslinking assay; and identification of
proteins in the selected fractions by mass spectrometry (Fig-
ure 5D). This method for identification of proteins interacting
with nascent chains (iPINCH) is a valuable tool for identification
of partners in transient protein-protein interactions during
translation.
RNCs of D4L PPL containing the photocrosslinking probe
were prepared in an in vitro translation system. As expected
the nascent chain of the mutated protein photocrosslinked
the !100K protein (Figure 5E, lane RNC). Washing the RNCs
with high-salt buffer removed most of the !100 kDa protein,
but upon adding lysate back to salt-washed RNCs, photocros-
slinking to the !100 kDa protein was reconstituted (Figure 5E,
lane ‘‘Lysate’’). A crude reticulocyte preparation of ribosome-
associated proteins, which restored photoadduct formation,
was fractionated and fractions containing the protein of interest
were identified (Figure 5E, fractions 8–10). Analysis by mass
spectroscopy revealed that the protein was Argonaute2
(Ago2) (Table S2). Ago2, a member of the argonaute protein
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Figure 5. Ago2 is in Cl se Proximity to Mutant Nascent Chains and
Associated with Mutant mRNA
(A) Deletions in the PPL signal sequence lead to reduced interaction with
SRP54 and increased proximity to a !100 kDa protein. Photocrosslinking
patterns of WT and mutated PPLs are shown. RNCs containing the first 86
residues of WT and mutant PPLs with a photoreactive probe in the signal
sequence were produced in vitro in the presence of SRP. Following UV irra-
diati n, sample were analyzed by electro h resis and autoradiography. The
positions of photoadducts containing !50 kDa (circle) or !100 kDa (diamond)
proteins are shown.
(B) Immunoprecipitation (IP) using SRP54 specific antibody demonstrates that
the !50 kDa protein is SRP54.
(C) WT PPL crosslinks to the !100 kDa protein are maximized when lysate is
not supplemented with SRP.
(D) Scheme of the method for identification of proteins interacting with nascent
chains (iPINCH).
(E) Identification of fractions that contain the !100 kDa protein. D4L RNCs
were prepared as above and treated with a high-salt buffer. The latter were
combined with lysate or aliquots of fractionated rabbit reticulocyte ribosome-
associated proteins, incubated, UV irradiated and analyzed as in A. The
photocrosslinking pattern of the fraction examined by mass spectrometry is
boxed.
(F) Recombinant Ago2 is in close proximity to mutant nascent chain. Purified
recombinant human Ago2 or buffer was added to salt-washed RNCs of D4L
PPL mutant with photocrosslinking probe. Samples were photocrosslinked
and analyzed as above.
(G) mRNA of D4L PPL is preferentially enriched in Ago2 immunoprecipitates. A
short incubation time (20–24 hr after plasmid transfection) was used to ensure
that significant levels ofD4LmRNA still remained at the start of the experiment:
the WT and D4L mutant mRNA content in cell lysates was about 2:1 before IP
(inset). Mouse monoclonal Ago2 antibody was used for IP. Data are from two
qPCRs, reactions were in triplicates, mean ± SD.
See also Figure S4 and Table S2.
152 Cell 156, 146–157, January 16, 2014 ª2014 Elsevier Inc.
with WT PPL when the reaction was not supplemented with
SRP (Figure 5C). This behavior implicated the !100 kDa pro-
tein in the initial step of the process that leads to the specific
degradation of mutant PPL mRNA or WT PPL mRNA when
SRP is limiting.
Argonaute2 is in Close Proximity to Mutant Nascent
Chains during Translation and Associates with
Mutant mRNA
To identify proteins interacting with nascent chains we combined
site-specific photocrosslinking with protein fractionation and
mass spectrometry. This allowed identification of proteins
involved in short-lived, transient interactions during translation.
The approach includes: in vitro preparation of salt-washed
RNC complexes with an incorporated photocrosslinking probe,
by the use of modified amber-suppressor tRNA (salt-washing
removes ribosome-associated proteins); fractionation of cellular
proteins, and selection of fractions containing the protein of
interest using the photocrosslinking assay; and identification of
proteins in the selected fractions by mass spectrometry (Fig-
ure 5D). This method for identification of proteins interacting
with nascent chains (iPINCH) is a valuable tool for identification
of partners in transient protein-protein interactions during
translation.
RNCs of D4L PPL containing the photocrosslinking probe
were prepared in an in vitro translation system. As expected
the nascent chain of the mutated protein photocrosslinked
the !100K protein (Figure 5E, lan RNC). Washing the RNCs
with high-salt buffer removed most of the !100 kDa protein,
but upon adding lysate back to salt-washed RNCs, photocros-
slink ng to the !100 kDa protein was reconstituted (Figure 5E,
lane ‘‘Lysate’’). A crude reticulocyte preparation of ribosome-
as ociated proteins, which restored photoadduct formation,
was fra tionated and fractions o tai i g the protein of interest
were identified (Figure 5E, fractions 8–10). Analysis by mass
spectroscopy revealed that the protein was Argonaute2
(Ago2) (Table S2). Ago2, a member of the argonaute protein
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Figure 5. Ago2 is in Close Proximity to Mutant Nascent Chains and
Associated with Mutant mRNA
(A) Deletions in the PPL signal sequence lead to reduced interaction with
SRP54 and increased proximity to a !100 kDa protein. Photocrosslinking
patterns of WT and mutated PPLs are shown. RNCs containing the first 86
residues of WT and mutant PPLs with a photoreactive probe in the signal
sequence were produced in vitro in the presence of SRP. Following UV irra-
diation, samples were analyzed by electrophoresis and autoradiography. The
positions of photoadducts containing !50 kDa (circle) or !100 kDa (diamond)
proteins are shown.
(B) Immunoprecipitation (IP) using SRP54 specific antibody demonstrates that
the !50 kDa protein is SRP54.
(C) WT PPL crosslinks to the !100 kDa protein are maximized when lysate is
not supplemented with SRP.
(D) Scheme of the method for identification of proteins interacting with nascent
chains (iPINCH).
(E) Identification of fractions that contain the !100 kDa protein. D4L RNCs
were prepared as above and treated with a high-salt buffer. The latter were
combined with lysate or aliquots of fractionated rabbit reticulocyte ribosome-
associated prot ins, incubated, UV irradiated and analyzed as in A. The
photocrosslinking pattern of the fraction examined by mass spectrometry is
boxed.
(F) Recombinant Ago2 is in close proximity to mutant nascent chain. Purified
recombinant human Ago2 or buffer was added to salt-washed RNCs of D4L
PPL mutant with photocrosslinking probe. Samples were photocrosslinked
and analyzed as above.
(G) mRNA of D4L PPL is preferentially enriched in Ago2 immunoprecipitates. A
short incubati n time (20–24 hr after plasmid transfection) was used to ensure
that significant levels ofD4LmRNA still remained at the start of the experiment:
the WT and D4L mutant mRNA content in cell lysates was about 2:1 before IP
(inset). Mouse monoclonal Ago2 antibody was used for IP. Data are from two
qPCRs, reactions were in triplicates, mean ± SD.
See also Figure S4 and Table S2.
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with WT PPL when the reaction was not supplemented with
SRP (Figure 5C). This behavior implicated the !100 kDa pro-
tein in the initial step of the process that leads to the specific
degradation of mutant PPL mRNA or WT PPL mRNA when
SRP is limiting.
Argonaute2 is in Close Proximity to Mutant Nascent
Chains during Translation and Associates with
Mutant mRNA
To identify proteins interacting with nascent chains we combined
site-specific photocrosslinking with protein fractionation and
mass spectrometry. This allowed identification of proteins
involved in short-lived, transient interactions during translation.
The approach includes: in vitro preparation of salt-washed
RNC complexes with an incorporated photocrosslinking probe,
by the use of modified amber-suppressor tRNA (salt-washing
removes ribosome-associated proteins); fractionation of cellular
proteins, and selection of fractions containing the protein of
interest using the photocrosslinking assay; and identification of
proteins in the selected fractions by mass spectrometry (Fig-
ure 5D). This method for identification of proteins interacting
with nascent chains (iPINCH) is a valuable tool for identification
of partners in transient protein-protein interactions during
translation.
RNCs of D4L PPL containing the photocrosslinking probe
were prepared in an in vitro translation system. As expected
the nascent chain of the mutated protein photocrosslinked
the !100K protein (Figure 5E, lane RNC). Washing the RNCs
with high-salt buffer removed most of the !100 kDa protein,
but upon adding lysate back to salt-washed RNCs, photocros-
slinking to the !100 kDa protein was reconstituted (Figure 5E,
lane ‘‘Lysate’’). A crude reticulocyte preparation of ribosome-
associated proteins, which restored photoadduct formation,
was fractionated and fractions containing the protein of interest
were identified (Figure 5E, fractions 8–10). Analysis by mass
spectroscopy revealed that the protein was Argonaute2
(Ago2) (Table S2). Ago2, a member of the argonaute protein
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Figure 5. Ago2 is in Close Proximity to Mutant Nascent Chains and
Associated with Mutant mRNA
(A) Deletions in the PPL signal sequence lead to reduced interaction with
SRP54 and increased proximity to a !100 kDa protein. Photocrosslinking
patterns of WT and mutated PPLs are shown. RNCs containing the first 86
residues of WT and mutant PPLs with a photoreactive probe in the signal
sequence were produced in vitro in the presence of SRP. Following UV irra-
diation, samples were analyzed by electrophoresis and autoradiography. The
positions of photoadducts containing !50 kDa (circle) or !100 kDa (diamond)
proteins are shown.
(B) Immunoprecipitation (IP) using SRP54 specific antibody demonstrates that
the !50 kDa protein is SRP54.
(C) WT PPL crosslinks to the !100 kDa protein are maximized when lysate is
not supplemented with SRP.
(D) Scheme of the method for identification of proteins interacting with nascent
chains (iPINCH).
(E) Identification of fractions that contain the !100 kDa protein. D4L RNCs
were prepared as above and treated with a high-salt buffer. The latter were
combined with lysate or aliquots of fractionated rabbit reticulocyte ribosome-
associated proteins, incubated, UV irradiated and analyzed as in A. The
photocrosslinking pattern of the fraction examined by mass spectrometry is
boxed.
(F) Recombinant Ago2 is in close proximity to mutant nascent chain. Purified
recombinant human Ago2 or buffer was added to salt-washed RNCs of D4L
PPL mutant with photocrosslinking probe. Samples were photocrosslinked
and analyzed as above.
(G) mRNA of D4L PPL is preferentially enriched in Ago2 immunoprecipitates. A
short incubation time (20–24 hr after plasmid transfection) was used to ensure
that significant levels ofD4LmRNA still remained at the start of the experiment:
the WT and D4L mutant mRNA content in cell lysates was about 2:1 before IP
(inset). Mouse monoclonal Ago2 antibody was used for IP. Data are from two
qPCRs, reactions were in triplicates, mean ± SD.
See also Figure S4 and Table S2.
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with WT PPL when the reaction was not supplemented with
SRP (Figure 5C). This behavior implicated the !100 kDa pro-
tein in the initial step of the process that leads to the specific
degradation of mutant PPL mRNA or WT PPL mRNA when
SRP is limiting.
Argonaute2 is in Close Proximity to Mutant Nascent
Chains during Translation and Associates with
Mutant mRNA
To identify proteins interacting with nascent chains we combined
site-specific photocrosslinking with protein fractionation and
mass spectrometry. This allowed identification of proteins
involved in short-lived, transient interactions during translation.
The approach includes: in vitro preparation of salt-washed
RNC complexes with an incorporated photocrosslinking probe,
by the use of modified amber-suppressor tRNA (salt-washing
removes ribosome-associated proteins); fractionation of cellular
proteins, and selection of fractions containing the protein of
interest using the photocrosslinking assay; and identification of
proteins in the selected fractions by mass spectrometry (Fig-
ure 5D). This method for identification of proteins interacting
with nascent chains (iPINCH) is a valuable tool for identification
of partners in transient protein-protein interactions during
translation.
RNCs of D4L PPL containing the photocrosslinking probe
were prepared in an in vitro translation system. As expected
the nascent chain of the mutated protein photocrosslinked
the !100K protein (Figure 5E, lane RNC). Washing the RNCs
with high-salt buffer removed most of the !100 kDa protein,
but upon adding lysate back to salt-washed RNCs, photocros-
slinking to the !100 kDa protein was reconstituted (Figure 5E,
lane ‘‘Lysate’’). A crude reticulocyte preparation of ribosome-
associated proteins, which restored photoadduct formation,
was fractionated and fractions containing the protein of interest
were identified (Figure 5E, fractions 8–10). Analysis by mass
spectroscopy revealed that the protein was Argonaute2
(Ago2) (Table S2). Ago2, a member of the argonaute protein
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Figure 5. Ago2 is in Close Proximity to Mutant Nascent Chains and
Associated with Mutant mRNA
(A) Deletions in the PPL signal sequence lead to reduced interaction with
SRP54 and increased proximity to a !100 kDa protein. Photocrosslinking
patterns of WT and mutated PPLs are shown. RNCs containing the first 86
residues of WT and mutant PPLs with a photoreactive probe in the signal
sequence were produced in vitro in the presence of SRP. Following UV irra-
diation, samples were analyzed by electrophoresis and autoradiography. The
positions of photoadducts containing !50 kDa (circle) or !100 kDa (diamond)
proteins are shown.
(B) Immunoprecipitation (IP) using SRP54 specific antibody demonstrates that
the !50 kDa protein is SRP54.
(C) WT PPL crosslinks to the !100 kDa protein are maximized when lysate is
not supplemented with SRP.
(D) Scheme of the method for identification of proteins interacting with nascent
chains (iPINCH).
(E) Identification of fractions that contain the !100 kDa protein. D4L RNCs
were prepared as above and treated with a high-salt buffer. The latter were
combined with lysate or aliquots of fractionated rabbit reticulocyte ribosome-
associated proteins, incubated, UV irradiated and analyzed as in A. The
photocrosslinking pattern of the fraction examined by mass spectrometry is
boxed.
(F) Recombinant Ago2 is in close proximity to mutant nascent chain. Purified
recombinant human Ago2 or buffer was added to salt-washed RNCs of D4L
PPL mutant with photocrosslinking probe. Samples were photocrosslinked
and analyzed as above.
(G) mRNA of D4L PPL is preferentially enriched in Ago2 immunoprecipitates. A
short incubation time (20–24 hr after plasmid transfection) was used to ensure
that significant levels ofD4LmRNA still remained at the start of the experiment:
the WT and D4L mutant mRNA content in cell lysates was about 2:1 before IP
(inset). Mouse monoclonal Ago2 antibody was used for IP. Data are from two
qPCRs, reactions were in triplicates, mean ± SD.
See also Figure S4 and Table S2.
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wit WT PPL when the reaction was not supplemented with
SRP (Figure 5C). This behavior implicated the !100 kDa pro-
tein in the initial step of the process that leads to the specific
degradation of mutant PPL mRNA or WT PPL mRNA when
SRP is limiting.
Argonaute2 is in Close Proximity to Mutant Nascent
Chains during Translation and Associates with
Mutant mRNA
To identify proteins interacting with nascent chains we combined
site-specific photocrosslinking with protein fractionation and
ma s spectrometry. This allowed iden ification of proteins
involved in short-liv , transient inter ctions during translation.
The approach includes: in vitro preparation of salt-washed
RNC complexes with an incorporated photocrosslinking probe,
by the use of modified amber-suppressor tRNA (salt-washing
removes ribosome-as oci ted pr teins); fractionation of cellular
p oteins, and selecti n of fractio s containing the protein of
interest using the photocrosslinking assay; and identification of
proteins in the selected fractions by mass spectrometry (Fig-
ure 5D). This method for identification of proteins interacting
with nasc nt chains (iPINCH) is a v luable tool for identification
of partners in transient pro ein-protein interactions during
translation.
RNCs of D4L PPL containing the photocrosslinking probe
were prepared in an in vitro translation system. As expected
the nascent chain of the mutated protein photocrosslinked
the !100K protein (Figure 5E, lane RNC). Washing the RNCs
with high-salt buffer removed most of the !100 kDa protein,
but upon adding lysate back to salt-washed RNCs, photocros-
slinking to the !100 kDa protein was reconstituted (Figure 5E,
lane ‘‘Lysate’’). A crude reticulocyte preparation of ribosome-
associated proteins, which restored photoadduct formation,
was fractionated and fractions containing the protein of interest
were identified (Figure 5E, fractions 8–10). Analysis by mass
spectroscopy revealed that the protein was Argonaute2
(Ago2) (Table S2). Ago2, a member of the argonaute protein
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Figure 5. Ago2 is in Close Proximity to Mutant Nascent Chains and
Associated with Mutant mRNA
(A) Deletions in the PPL signal sequence lead to reduced interaction with
SRP54 and increased proximity to a !100 kDa protein. Photocrosslinking
patterns of WT and mutated PPLs are shown. RNCs containing the first 86
residues of WT and mutant PPLs with a photoreactive probe in the signal
sequence were produced in vitro in the presence of SRP. Following UV irra-
diation, samples were analyzed by electrophoresis and autoradiography. The
positions of photoadducts containing !50 kDa (circle) or !100 kDa (diamond)
proteins are shown.
(B) Immunoprecipitation (IP) using SRP54 specific antibody demonstrates that
the !50 kDa protein is SRP54.
(C) WT PPL crosslinks to the !100 kDa protein are maximized when lysate is
not supplemented with SRP.
(D) Scheme of the method for identification of proteins interacting with nascent
chains (iPINCH).
(E) Identification of fractions that contain the !100 kDa protein. D4L RNCs
were prepared as above a d tr ated with a high-salt buffer. The latter were
combined with lysate or aliquots of fracti nated r bbit reticulocyte ribosome-
associated proteins, incubated, UV irradiated and analyzed as in A. The
photocrosslinking pattern of the fraction examined by mass spectrometry is
boxed.
(F) Recombinant Ago2 is in close proximity to mutant nascent chain. Purified
recombinant human Ago2 or buffer was added to salt-washed RNCs of D4L
PPL mutant with photocrosslinking probe. Samples were photocrosslinked
and analyzed as above.
(G) mRNA of D4L PPL is preferentially enriched in Ago2 immunoprecipitates. A
short incubation time (20–24 hr after plasmid transfection) was used to e sure
that significant levels ofD4LmRNA still remained at the start of the experiment:
the WT and D4L mutant mRNA content in cell lysates was about 2:1 before IP
(inset). Mouse monoclonal Ago2 antibody was used for IP. Data are from two
qPCRs, reactions were in triplicates, mean ± SD.
See also Figure S4 and Table S2.
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with WT PPL when the reaction was not supplemented with
SRP (Figure 5C). This behavior implicated the !100 kDa pro-
tein in the initial step of the process that leads to the specific
degradation of mutant PPL mRNA or WT PPL mRNA when
SRP is limiting.
Argonaute2 is in Close Proximity to Mutant Nascent
Chains during Translation and Associates with
Mutant mRNA
To identify proteins interacting with nascent chains we combined
site-specific photocrosslinking with protein fractionation and
mass spectrometry. This allowed identification of proteins
involved in short-lived, transient interactions during translation.
The approach includes: in vitro preparation of salt-washed
RNC complexes with an incorporated photocrosslinking probe,
by the use of modified amber-suppressor tRNA (salt-washing
removes ribosome-associated proteins); fractionation of cellular
proteins, and selection of fractions containing the protein of
interest using the photocrosslinking assay; and identification of
proteins in the selected fractions by mass spectrometry (Fig-
ure 5D). This method for identification of proteins interacting
with nascent chains (iPINCH) is a valuable tool for identification
of partners in transient protein-protein interactions during
translation.
RNCs of D4L PPL containing the photocrosslinking probe
were prepared in an in vitro translation system. As expected
the nascent chain of the mutated protein photocrosslinked
the !100K protein (Figure 5E, lane RNC). Washing the RNCs
with high-salt buffer removed most of the !100 kDa protein,
but upon adding lysate back to salt-washed RNCs, photocros-
slinking to the !100 kDa protein was reconstituted (Figure 5E,
lane ‘‘Lysate’’). A crude reticulocyte preparation of ribosome-
associated proteins, which restored photoadduct formation,
was fractionated and fractions containing the protein of interest
were identified (Figure 5E, fractions 8–10). Analysis by mass
spectroscopy revealed that the protein was Argonaute2
(Ago2) (Table S2). Ago2, a member of the argonaute protein
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Figure 5. Ago2 is in Close Proximity to Mutant Nascent Chains and
Associated with Mutant mRNA
(A) Deletions in the PPL signal sequence lead to reduced interaction with
SRP54 and increased proximity to a !100 kDa protein. Photocrosslinking
patterns of WT and mutated PPLs are shown. RNCs containing the first 86
residues of WT and mutant PPLs with a photoreactive probe in the signal
sequence were produced in vitro in the presence of SRP. Following UV irra-
diation, samples were analyzed by electrophoresis and autoradiography. The
positions of photoadducts containing !50 kDa (circle) or !100 kDa (diamond)
proteins are shown.
(B) Immunoprecipitation (IP) using SRP54 specific antibody demonstrates that
the !50 kDa protein is SRP54.
(C) WT PPL crosslinks to the !100 kDa protein are maximized when lysate is
not supplemented with SRP.
(D) Scheme of the method for identification of proteins interacting with nascent
chains (iPINCH).
(E) Identification of fractions that contain the !100 kDa protein. D4L RNCs
were prepared as above and treated with a high-salt buffer. The latter were
combined with lysate or aliquots of fractionated rabbit reticulocyte ribosome-
associated proteins, incubated, UV irradiated and analyzed as in A. The
photocrosslinking pattern of the fraction examined by mass spectrometry is
boxed.
(F) Recombinant Ago2 is in close proximity to mutant nascent chain. Purified
recombinant human Ago2 or buffer was added to salt-washed RNCs of D4L
PPL mutant with photocrosslinking probe. Samples were photocrosslinked
and analyzed as above.
(G) mRNA of D4L PPL is preferentially enriched in Ago2 immunoprecipitates. A
short incubation time (20–24 hr after plasmid transfection) was used to ensure
that significant levels ofD4LmRNA still remained at the start of the experiment:
the WT and D4L mutant mRNA content in cell lysates was about 2:1 before IP
(inset). Mouse monoclonal Ago2 antibody was used for IP. Data are from two
qPCRs, reactions were in triplicates, mean ± SD.
See also Figure S4 and Table S2.
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with WT PPL when the reaction was not supplemented with
SRP (Figure 5C). This behavior implicated the !100 kDa pro-
tein in the initial step of the process that leads to the specific
degradation of mutant PPL mRNA or WT PPL mRNA when
SRP is limiting.
Argonaute2 is in Close Proximity to Mutant Nascent
Chains during Translation and Associates with
Mutant mRNA
To identify proteins interacting with nascent chains we combined
site-specific photocrosslinking with protein fractionation and
mass spectrometry. This allowed identification of proteins
involved in short-lived, transient interactions during translation.
The approach includes: in vitro preparation of salt-washed
RNC complexes with an incorporated photocrosslinking probe,
by the use of modified amber-suppressor tRNA (salt-washing
removes ribosome-associated proteins); fractionation of cellular
proteins, and selection of fractions containing the protein of
interest using the photocrosslinking assay; and identification of
proteins in the selected fractions by mass spectrometry (Fig-
ure 5D). This method for identification of proteins interacting
with nascent chains (iPINCH) is a valuable tool for identification
of partners in transient protein-protein interactions during
translation.
RNCs of D4L PPL containing the photocrosslinking probe
were prepared in an in vitro translation system. As expected
the nascent chain of the mutated protein photocrosslinked
the !100K protein (Figure 5E, lane RNC). Washing the RNCs
with high-salt buffer removed most of the !100 kDa protein,
but upon adding lysate back to salt-washed RNCs, photocros-
slinking to the !100 kDa protein was reconstituted (Figure 5E,
lane ‘‘Lysate’’). A crude reticulocyte preparation of ribosome-
associated proteins, which restored photoadduct formation,
was fractionated and fractions containing the protein of interest
were identified (Figure 5E, fractions 8–10). Analysis by mass
spectroscopy revealed that the protein was Argonaute2
(Ago2) (Table S2). Ago2, a member of the argonaute protein
A B C
D
E
F G
Figure 5. Ago2 is in Close Proximity to Mutant Nascent Chains and
Associated with Mutant mRNA
(A) Deletions in the PPL signal sequence lead to reduced interaction with
SRP54 and increased proximity to a !100 kDa protein. Photocrosslinking
patterns of WT and mutated PPLs are shown. RNCs containing the first 86
residues of WT and mutant PPLs with a photoreactive probe in the signal
sequence were produced in vitro in the presence of SRP. Following UV irra-
diation, samples were analyzed by electrophoresis and autoradiography. The
positions of photoadducts containing !50 kDa (circle) or !100 kDa (diamond)
proteins are shown.
(B) Immunoprecipitation (IP) using SRP54 specific antibody demonstrates that
the !50 kDa protein is SRP54.
(C) WT PPL crosslinks to the !100 kDa protein are maximized when lysate is
not supplemented with SRP.
(D) Scheme of the method for identification of proteins interacting with nascent
chains (iPINCH).
(E) Identification of fractions that contain the !100 kDa protein. D4L RNCs
were prepared as above and treated with a high-salt buffer. The latter were
combined with lysate or aliquots of fractionated rabbit reticulocyte ribosome-
associated proteins, incubated, UV irradiated and analyzed as in A. The
photocrosslinking pattern of the fraction examined by mass spectrometry is
boxed.
(F) Recombinant Ago2 is in close proximity to mutant nascent chain. Purified
recombinant human Ago2 or buffer was added to salt-washed RNCs of D4L
PPL mutant with photocrosslinking probe. Samples were photocrosslinked
and analyzed as above.
(G) mRNA of D4L PPL is preferentially enriched in Ago2 immunoprecipitates. A
short incubation time (20–24 hr after plasmid transfection) was used to ensure
that significant levels ofD4LmRNA still remained at the start of the experiment:
the WT and D4L mutant mRNA content in cell lysates was about 2:1 before IP
(inset). Mouse monoclonal Ago2 antibody was used for IP. Data are from two
qPCRs, reactions were in triplicates, mean ± SD.
See also Figure S4 and Table S2.
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with WT PPL when the reaction was not supplemented with
SRP (Figure 5C). This behavior implicated the !100 kDa pro-
tein in the initial step of the process that leads to the specific
degradation of mutant PPL mRNA or WT PPL mRNA when
SRP is limiting.
Argonaute2 is in Close Proximity to Mutant Nascent
Chains during Translation and Associates with
Mutant mRNA
To identify proteins interacting with nascent chains we combined
site-specific photocrosslinking with protein fractionation and
mass spectrometry. This allowed identification of proteins
involved in short-lived, transient interactions during translation.
The approach includes: in vitro preparation of salt-washed
RNC complexes with an incorporated photocrosslinking probe,
by the use of modified amber-suppressor tRNA (salt-washing
removes ribosome-associated proteins); fractionation of cellular
proteins, and selection of fractions containing the protein of
interest using the photocrosslinking assay; and identification of
proteins in the selected fractions by mass spectrometry (Fig-
ure 5D). This method for identification of proteins interacting
with nascent chains (iPINCH) is a valuable tool for identification
of partners in transient protein-protein interactions during
translation.
RNCs of D4L PPL containing the photocrosslinking probe
were prepared in an in vitro translation system. As expected
the nascent chain of the mutated protein photocrosslinked
the !100K protein (Figure 5E, lane RNC). Washing the RNCs
with high-salt buffer removed most of the !100 kDa protein,
but upon adding lysate back to salt-washed RNCs, photocros-
slinking to the !100 kDa protein was reconstituted (Figure 5E,
lane ‘‘Lysate’’). A crude reticulocyte preparation of ribosome-
associated proteins, which restored photoadduct formation,
was fractionated and fractions containing the protein of interest
were identified (Figure 5E, fractions 8–10). Analysis by mass
spectroscopy revealed that the protein was Argonaute2
(Ago2) (Table S2). Ago2, a member of the argonaute protein
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Figure 5. Ago2 is in Close Proximity to Mutant Nascent Chains and
Associated with Mutant mRNA
(A) Deletions in the PPL signal sequence lead to reduced interaction with
SRP54 and increased proximity to a !100 kDa protein. Photocrosslinking
patterns of WT and mutated PPLs are shown. RNCs containing the first 86
residues of WT and mutant PPLs with a photoreactive probe in the signal
sequence were produced in vitro in the presence of SRP. Following UV irra-
diation, samples were analyzed by electrophoresis and autoradiography. The
positions of photoadducts containing !50 kDa (circle) or !100 kDa (diamond)
proteins are shown.
(B) Immunoprecipitation (IP) using SRP54 specific antibody demonstrates that
the !50 kDa protein is SRP54.
(C) WT PPL crosslinks to the !100 kDa protein are maximized when lysate is
not supplemented with SRP.
(D) Scheme of the method for identification of proteins interacting with nascent
chains (iPINCH).
(E) Identification of fractions that contain the !100 kDa protein. D4L RNCs
were prepared as above and treated with a high-salt buffer. The latter were
combined with lysate or aliquots of fractionated rabbit reticulocyte ribosome-
associated proteins, incubated, UV irradiated and analyzed as in A. The
photocrosslinking pattern of the fraction examined by mass spectrometry is
boxed.
(F) Recombinant Ago2 is in close proximity to mutant nascent chain. Purified
recombinant human Ago2 or buffer was added to salt-washed RNCs of D4L
PPL mutant with photocrosslinking probe. Samples were photocrosslinked
and analyzed as above.
(G) mRNA of D4L PPL is preferentially enriched in Ago2 immunoprecipitates. A
short incubation time (20–24 hr after plasmid transfection) was used to ensure
that significant levels ofD4LmRNA still remained at the start of the experiment:
the WT and D4L mutant mRNA content in cell lysates was about 2:1 before IP
(inset). Mouse monoclonal Ago2 antibody was used for IP. Data are from two
qPCRs, reactions were in triplicates, mean ± SD.
See also Figure S4 and Table S2.
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with WT PPL when the reaction was not supplemented with
SRP (Figure 5C). This behavior implicated the !100 kDa pro-
tein in the initial step of the process that leads to the specific
degradation of mutant PPL mRNA or WT PPL mRNA when
SRP is limiting.
Argonaute2 is in Close Proximity to Mutant Nascent
Chains during Translation and Associates with
Mutant mRNA
To identify proteins interacting with nascent chains we combined
site-specific photocrosslinking with protein fractionation and
mass spectrometry. This allowed identification of proteins
involved in short-lived, transient interactions during translation.
The approach includes: in vitro preparation of salt-washed
RNC complexes with an incorporated photocrosslinking probe,
by the use of modified amber-suppressor tRNA (salt-washing
removes ribosome-associated proteins); fractionation of cellular
proteins, and selection of fractions containing the protein of
interest using the photocrosslinking assay; and identification of
proteins in the selected fractions by mass spectrometry (Fig-
ure 5D). This method for identification of proteins interacting
with nascent chains (iPINCH) is a valuable tool for identification
of partners in transient protein-protein interactions during
translation.
RNCs of D4L PPL containing the photocrosslinking probe
were prepared in an in vitro translation system. As expected
the nascent chain of the mutated protein photocrosslinked
the !100K protein (Figure 5E, lane RNC). Washing the RNCs
with high-salt buffer removed most of the !100 kDa protein,
but upon adding lysate back to salt-washed RNCs, photocros-
slinking to the !100 kDa protein was reconstituted (Figure 5E,
lane ‘‘Lysate’’). A crude reticulocyte preparation of ribosome-
associated proteins, which restored photoadduct formation,
was fractionated and fractions containing the protein of interest
were identified (Figure 5E, fractions 8–10). Analysis by mass
spectroscopy revealed that the protein was Argonaute2
(Ago2) (Table S2). Ago2, a member of the argonaute protein
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Figure 5. Ago2 is in Close Proximity to Mutant Nascent Chains and
Associated with Mutant mRNA
(A) Deletions in the PPL signal sequence lead to reduced interaction with
SRP54 and increased proximity to a !100 kDa protein. Photocrosslinking
patterns of WT and mutated PPLs are shown. RNCs containing the first 86
residues of WT and mutant PPLs with a photoreactive probe in the signal
sequence were produced in vitro in the presence of SRP. Following UV irra-
diation, samples were analyzed by electrophoresis and autoradiography. The
positions of photoadducts containing !50 kDa (circle) or !100 kDa (diamond)
proteins are shown.
(B) Immunoprecipitation (IP) using SRP54 specific antibody demonstrates that
the !50 kDa protein is SRP54.
(C) WT PPL crosslinks to the !100 kDa protein are maximized when lysate is
not supplemented with SRP.
(D) Scheme of the method for identification of proteins interacting with nascent
chains (iPINCH).
(E) Identification of fractions that contain the !100 kDa protein. D4L RNCs
were prepared as above and treated with a high-salt buffer. The latter were
combined with lysate or aliquots of fractionated rabbit reticulocyte ribosome-
associated proteins, incubated, UV irradiated and analyzed as in A. The
photocrosslinking pattern of the fraction examined by mass spectrometry is
boxed.
(F) Recombinant Ago2 is in close proximity to mutant nascent chain. Purified
recombinant human Ago2 or buffer was added to salt-washed RNCs of D4L
PPL mutant with photocrosslinking probe. Samples were photocrosslinked
and analyzed s above.
(G) mRNA of D4L PPL is preferentially enriched in Ago2 immun precipitates. A
short incubation time (20–24 hr after plasmid transfection) was used to ensure
that significant levels ofD4LmRNA still remained at the start of the experiment:
the WT and D4L mutant mRNA content in cell lysates was about 2:1 before IP
(inset). Mouse monoclonal Ago2 antibody was used for IP. Data are from two
qPCRs, reactions were in triplicates, mean ± SD.
See also Figure S4 and Table S2.
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Figure S4. Cotranslational Site-Specific Photocrosslinking and RNA IP of Endogenous Ago2, Related to Figure 5
(A) Scheme of the site-specific incorporation of photocrosslinking probe into a protein. When an mRNA is mutated to contain an amber stop codon in position 18
of PPL, protein synthesis is prematurely terminated at this location in the absence of an aminoacylated amber suppressor tRNA (aa-tRNAamb). However, when a
translation incubation is supplemented with an aa-tRNAamb that has a photoreactive moiety covalently attached to the amino acid side chain (εANB-Lys-
tRNAamb), the photoreactive and uncharged εANB-Lys is incorporated into the nascent chain at position 18. A homogeneous population of RNCs with photo-
reactive nascent chains is obtained by translating truncated mRNAs that lack a stop codon (other than the amber codon at position 18 that is translated by the
amber suppressor) because normal termination does not occur and the nascent chain remains attached to the ribosome-bound peptidyl-tRNA. The length of the
nascent chain is then dictated by the length of the truncated mRNA.
(B) Formation of crosslinking products is photo-probe dependent. Nascent 86-residue preprolactin was synthesized in vitro in a wheat germ translation system
containing canine SRP in the presence of unmodified Lys-tRNAamb lacking a photoprobe (lane 1) or of εANB-Lys-tRNAamb (lanes 2–4). Samples were irradiated
with UV light (lanes 1–3) or not irradiated (lane 4). Samples were analyzed by 10%–15%gradient SDS-PAGE and autoradiography. The positions of photoadducts
to SRP54 (open circle) is shown.
(C–F) mRNA of D4L PPL is Preferentially Enriched in Ago2 Immunoprecipitates. (C-D) Additional panels for Figure 5G. IP was done with mouse monoclonal Ago2
antibody or control IgG. Ago2 was detected in immunoprecipitates by western blot using Ago2 rabbit antibodies (C). RT-PCR analysis of WT and the mutant PPL
mRNAs in immunoprecipitates (D). (E and F) Experiment similar to those shown in Figures 5G and S4C, but with usage of independent Ago2 antibody (rabbit) for
IP.WT andD4L PPLmRNAswere quantified by qPCR (E). TheWT andD4Lmutant mRNA content in cell lysates was about 2:1 before IP (inset). Data are from two
qPCRs, reactions were in triplicates, mean ± SD. Ago2 was detected in immunoprecipitates by western blot using Ago2 mouse monoclonal antibodies (F).
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family, is involved in gene silencing (Hammond et al., 2001;
Hutvagner and Simard, 2008; Martinez et al., 2002; Tolia and
Joshua-Tor, 2007). The identification of Ago2 was validated
independently by reconstituting the photoadduct using recom-
binant human Ago2 purified from insect cells (Figure 5F),
confirming its close proximity to mutated PPL-nascent chain
during translation.
We tested whether Ago2 preferentially interacts with the
mutant mRNA. RNA immunoprecipitation (RNA-IP) of endoge-
nous Ago2 from human cells expressing WT or mutant PPLs
revealed that mutant D4L PPL mRNA was enriched in Ago2
immunoprecipitates (Figures 5G and S4C–S4F).
To test functional involvement of Ago2 in the specific reduc-
tion of mutant mRNA levels we measured PPL mRNA levels in
the cultured cells in which Ago2 was depleted or overex-
pressed. The reduction of mutant PPL mRNA was significantly
inhibited in cells when Ago2 was knocked-down (D4L mRNA
level increased !4.4-fold, Figure 6A), while WT mRNA level
was elevated in Ago2 knockdown cells to a lesser degree
(!1.7-fold). The results suggest that Ago2 is involved in the
process of specific mRNA degradation. For Ago2 overexpres-
sion experiments, Ago2-containing plasmids were transfected
a day before transfection with PPL plasmids. A short incuba-
tion time (!24 hr after PPL plasmids’ transfections) was
used to ensure that significant level of D4L mRNA (about
45% of WT PPL mRNA level) still remained in the control (Fig-
ure 6B). When Ago2 was overexpressed, the level of D4L
mRNA was dramatically reduced (!6.2-fold), while WT PPL
mRNA level was decreased to a lesser degree (!3.3-fold)
(Figure 6B).
Although Ago2 possesses ribonuclease H activity (slicer
activity) and amino acid residues in the active site are known
(Liu et al., 2004; Song et al., 2004), not all Ago2-dependent
processes require its nuclease activity. To test if Ago2 slicer
activity is required for mutant PPL mRNA degradation we con-
ducted experiments with a slicer defective Ago2, containing
mutation D597A (Liu et al., 2004; Rivas et al., 2005). Overpro-
duction of Ago2-D597A leads to significant decrease in the
level of D4L mRNA, and to lesser degree, WT PPL mRNA (Fig-
ures 6B). Although the effect of Ago2-D597A was slightly less
than that of Ago2-WT, the results demonstrate that over-
production of slicer mutant Ago2 leads to decreased levels
of PPL mRNAs. Overproduction of Ago2-WT or mutant
Ago2-D597A under conditions when endogenous Ago2 was
knocked-down independently confirmed this observation (Fig-
ure S5A) and showed that the effects were specific (Fig-
ure S5B). These results indicate that Ago2 is involved in the
process, but its slicer activity is not required. Interestingly,
knock down of other proteins of the argonaute family, Ago1,
Ago3, and Ago4, and proteins involved in small RNA biogen-
esis, Dicer and Drosha, as well as proteins involved in
miRNA-dependent association with Ago2, TNRC6A, B, C,
were without measurable effect on D4L PPL mutant mRNA
levels (Figures S5C–S5H). Modest increases in mRNA levels
of WT PPL mRNA in some cases was observed, reflecting
involvement of the above proteins in normal PPL mRNA
biogenesis, however, the knockdowns did not significantly
affect the process of mutant mRNA elimination.
DISCUSSION
Misfolded/mistargeted proteins, as well as their aggregates can
be cytotoxic, leading to many diseases (Stefani and Dobson,
2003). However, the fact that protein aggregates do not accumu-
late in unstressed cells despite their potential continued produc-
tion indicates the existence of efficient quality control machinery
(Kopito, 2000). Cells have developed multiple mechanisms for
protection from these ‘‘unwanted’’ products at different levels.
One of the protection levels is labeling with ubiquitin and degra-
dation of already synthesized aberrant proteins by the pro-
teasome (Buchberger et al., 2010; Smith et al., 2011).
Energy-dependent degradation of mutant proteins and their
futile translation are expensive processes and cells evolved
mechanisms to prevent synthesis of mutant cytotoxic proteins.
NMD directing mRNAswith premature stop codons for degrada-
tion, NSD acting on mRNAs without a natural stop codon, and
NGD acting on mRNAs on stalled ribosomes, are examples of
quality control on the templatemRNAswith dramatic aberrations
(Doma and Parker, 2007; Shoemaker and Green, 2012). Howev-
er, none of these systems are known to act on mutant mRNA
templates that code for proteins with small aberrations in their
primary structure. The mechanism reported here fills this gap
in quality control by specifically acting on mutant mRNA tem-
plates encoding proteins that have lost interactions with their
normal binding partners at the ribosome exit site.
In this study we report the discovery of a previously unappre-
ciated mechanism of translational quality control, in which trans-
lation of a defective protein leads to specific degradation of its
mRNA. Thismechanismmonitors the absence of normal interac-
tions of nascent chains early during translation and transfers the
A B
Figure 6. Process of mRNA Degradation Involves Ago2
(A and B) Ago2 knockdown inhibited reduction of PPL mRNA (A), while over-
production of recombinant WT or mutant D597A Myc-Ago2 reduced the level
of PPLmRNA (B). Bars are PPLmRNA levels from northern blot (n = 3 [but n = 2
for D597A], mean ± SEM). WT PPL mRNA levels are open bars, D4L mutants
are black bars. Depletion or overexpression of Ago2was confirmed bywestern
blot, actin was a control. See also Figure S5.
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Figure S5. Ago2 Slicer Activity, as well as Other Argonautes, Human Paralogues of GW182, and Proteins Involved in Small RNA Biogenesis
are Not Required for Specific Degradation of the Mutant D4L PPL mRNA, Related to Figure 6
(A) Effect of overproduction of Ago2-WT or mutant Ago2-D597A onWT PPL (open bars) or D4L mutant (black bars) mRNA levels under conditions of endogenous
Ago2 knockdown. The cells were first treated with endogenous Ago2 specific siRNAs (target 30-UTR of endogenous Ago2, the sequence is absent in the re-
combinant Ago2) or control siRNA (siContr), Ago2 expression plasmids were transfected the next day, and PPL containing plasmids were transfected a day later,
and cells were incubated for 42 hr after PPL transfections. Bars are PPLmRNA levels from northern blot (n = 3, mean ±SEM). Depletion or overexpression of Ago2
was confirmed by western blot, actin was a control. (B) Actin mRNA levels in samples of the experiment presented in A (northern blot, n = 3, mean ± SEM).
(C) Knockdowns of Ago1, Ago3, and Ago4 do not suppress PPL D4L mRNA reduction.
(D–H) Drosha and Dicer knockdowns lead to decreased level of mature miRNAs (Kumar et al., 2007), as it is shown on the examples of Let-7 and miR22 (D) and
consequently to increase in mRNA levels of miRNA regulated targets, as it is shown for a known Let-7 target (Lee and Dutta, 2007), HMGA2 (E). However, Drosha
and Dicer knockdowns do not suppress PPL D4L mRNA reduction (F and G). Consistent with miRNA-dependent regulation of HMGA2 expression, knockdowns
of TNRC6A, B, C lead to increase its mRNA level (E), however, do not suppress PPL D4L mRNA reduction (H).
mRNA and miRNA levels were measured by qPCR (n = 3, but controls n = 9 for C, F, H; n = 3 for D and E; n = 4 for G; mean ± SD). WT PPLs are open bars, D4L
mutants are black bars (A, C, F–H), Let-7 and miR22 levels are light gray and dark gray bars, correspondingly (D). See also Table S1.
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signal to mRNA degradation machinery that allows cells to pre-
vent synthesis of these ‘‘unwanted’’ aberrant proteins. This
process is distinct from known quality control mechanisms. It
involves surveillance of newly synthesized nascent chain interac-
tions and triggers mRNA degradation in response to a loss of
these normal interactions during translation. This mechanism
can discriminate between normal and mutated mRNAs even
when they are coexpressed (Figures 3B–3D). This specificity is
graded, as demonstrated by the strong correlation between
decreased efficiency of SRP-nascent chain interaction and
mRNA degradation (Figures 2A–2B and 5A). Therefore, the sys-
tem balances the quantity of synthesized protein with decreased
ability for targeting and secretion. Notably, this process is not a
generalized stress response but rather is specifically directed to
reduce the burden of nontransportable proteins aswell as poten-
tially other types of newly synthesized misfolded proteins.
Furthermore, as demonstrated by two different approaches,
introduction of deletions in signal sequences of several secretory
proteins and assessment of mRNA levels of secretory and ER
lumen proteins under conditions when SRP was depleted, the
mechanism is general (Figures 2).
Based on our data, we propose that the loss of cotranslational
interactions between a nascent chain and factors required for
transport and/or folding (SRP in this study, but possibly ribo-
some-associated chaperones for cytosolic proteins (Hartl
et al., 2011; Pechmann et al., 2013; Raue et al., 2007), and other
targeting factors for nuclear, mitochondrial, or peroxisomal pro-
teins) can trigger a cellular response that leads to specific elim-
ination of the corresponding mRNA (Figure 7). According to
this hypothesis, Ago2 is associated with the ribosome within
the reach of the nascent chains that are either defective or
unable to bind their normal binding partners after emerging
from the translating ribosome and the encoding mRNA. This
association correlates with mRNA elimination. Although it is still
unknown if Ago2 is a direct sensor, the data demonstrate that
Ago2 is functionally involved in the process. This mechanism
of regulation of aberrant protein production (RAPP) would
provide high flexibility for regulating the synthesis of aberrant
proteins regardless of their sequence and structure, without
negative effects on the production of undamaged proteins in
the same cell.
The following observations support this model: (1) Ago2
cotranslationally crosslinks to mutant nascent chains that have
lost the ability to bind SRP (Figure 5A); (2) in the absence of
SRP, nascent WT PPL photocrosslinks instead to Ago2 (Fig-
ure 5C), indicating that Ago2 occupies the space when it is not
occupied by SRP; (3) Ago2 was found preferentially associated
(directly or nondirectly) with the mutant mRNA (Figures 5G and
S4C–S4F); (4) overexpression of Ago2 or depletion of SRP in
human cells decreases the levels of PPL mRNA, while depletion
of Ago2 stabilizes the level of mutant mRNA (Figure 6); (5)
increase in Ago2 crosslinking efficiency directly correlates with
the number of leucines deleted from the PPL signal sequence,
a decrease in efficiency of RNC interaction with SRP, and a
decrease in the level of mutant mRNA (Figures 2A, 2B, and
5A); (6) mRNAs of secretory proteins with defective signal
sequences were efficiently degraded despite the absence of
homology in signal sequences (Figure 2E); (7) SRP knockdown
leads to mRNA degradation of even WT protein, while defects
in other downstream components of the protein translocation
machinery were without effect (Figures 2G–2I).
Several different scenarios were examined to determine which
signals are used for selection for degradation of mRNAs coding
aberrant proteins. The above model is the simplest model that
explains all the data. Indeed, direct surveillance of mRNA
sequence by a quality control mechanism is unlikely (see discus-
sion to Figure 4). A model in which the decreased stability is due
to mislocalization of ER-targeted mRNAs, or a mechanism
involving surveillance of the overall change in the structure of
synthesized aberrant secretory protein as a result of folding in
the cytosol, an inappropriate environment, is inconsistent with
the observations that knock down of SRP receptor or translocon
protein Sec61a did not effect the mRNA level of secretory pro-
teins, by contrast to SRP knockdown (Figure 2). All these defects
in components of the secretory machinery abolish protein trans-
location, but only SRP knock down leads to mRNA elimination.
Recognition of a specific sequence or features of an aberrant
protein (e.g., a mutated signal sequence) is inconsistent with
data on secretory proteins lacking their signal sequences or
with scrambled N termini (Figure 4). This scenario also cannot
explain secretory protein mRNA depletion when SRP was
knocked-down (Figures 2G, 2H, and 2J). Therefore the simplest
model is that the quality control system does not recognize spe-
cific sequences of a mutant protein or overall changes in its
Figure 7. Model for Regulation of Aberrant Protein Production
When the nascent chain of a WT secretory protein containing a signal
sequence emerges from the ribosome polypeptide exit tunnel during trans-
lation it is recognized by SRP. This interaction leads to targeting of the complex
to SRP receptor in the ERmembrane and finally to the translocon. The nascent
chain is cotranslationally translocated into the ER lumen, where it is folded with
the help of ER chaperones. However, when the nascent chain of a secretory
protein contains critical mutations preventing SRP recognition, the unbound
nascent chain is exposed outside the polypeptide tunnel. Despite the absence
of its interaction with SRP, a defective secretory protein does not typically
behave as a cytosolic protein because of the absence of appropriate
sequences/conformations/signals required for normal cytosolic nascent
chains interactions. Thus, the space normally occupied by SRP at the ribo-
some remains unoccupied. Ago2 occupies the space and directs mRNA for
degradation initiating the RAPP process.
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EXTENDED EXPERIMENTAL PROCEDURES
Plasmids, DNA Techniques, mRNA, and tRNA
pSPBP4 (Krieg et al., 1986) was used as a source of bovine PPL gene. Plasmids for expression of PPL in human cell cultures were
made with pBI-CMV2 (Clontech) and pCS2 vectors. For the mRNA stability/degradation experiments, WT and mutant PPLs were
cloned under control of the Tet-response element into vector pTRE2hyg (Clontech). For Ago2 expression in human cell culture,
humanAgo2was cloned into amodified pCS2-Myc vector containing FseI and AscI sites. For this purpose, the Ago2 genewas ampli-
fied from human fetal thymus cDNA (Clontech) by two consecutive PCR reactions with the primers 1823-1825 and the primers 1826-
1827 (Table S3). The resulting construct contains the human Ago2 with six Myc repeats at the N terminus under control of the CMV
promoter. The construct and protocol employed for expression and purification of human recombinant Ago2 from insect cells was
described previously (Ye et al., 2011). Carbonic anhydrase IV (CA4), and a1-antitrypsin (AT), were cloned into pBI-CMV2 vector and
deletions in signal sequences were done by site-directed mutagenesis. CA4 and AT lacking signal sequences were made by PCR,
hybrids containing the mature part of AT (Pro27–Lys418), or CA4 (Ala19–Arg312) and the WT PPL signal sequence (Met1-Thr31) or
the corresponding PPL D4L signal sequence were prepared by overlapping PCR. Pyruvate kinase (PK) (plasmid kindly provided by
Yuh Min Chook) (Zhang et al., 2011), and firefly luciferase (Luc) (pGL4.17, Promega) were cloned into pCS2 vector and the hybrids
containing WT PPL or D4L signal sequence (Met1-Thr31) and PK (Ser2-Pro531) or Luc (Glu2-Val550) sequences were prepared by
overlapping PCR. Site-directedmutagenesis was performed by a PCR technique using Pfu turbo or Pfu Ultra DNApolymerases (Stra-
tagene). All mutations were confirmed by DNA sequencing. DNA fragments for in vitro transcription were generated by standard PCR
techniques. For in vitro translation and photocrosslinking experiments mRNAs were transcribed in vitro using SP6 RNA polymerase
and PCR-produced DNA fragments of the desired length as before (Flanagan et al., 2003) and purified using the RNeasy Mini kit
(QIAGEN). Nε-(5-azido-2-nitrobenzoyl)-Lys-tRNAamb (εANB-Lys-tRNAamb) was prepared as described earlier (Flanagan et al.,
2003; McCormick et al., 2003). This tRNA contains an anticodon that recognizes an amber stop codon in mRNA. Briefly, tRNAamb
was synthesized in vitro by T7 RNA polymerase, purified by chromatography on MonoQ column, aminoacylated with [14C]Lys
in vitro, purified again on the same column, and chemically modified with ANB. This εANB-Lys-tRNAamb was used for photocross-
linking experiments.
Antibodies
The following antibodies were used in the current work: mouse monoclonal prolactin antibody (Thermo Fisher), mouse monoclonal
antibody specific to human SRP54 (BD Bioscience), affinity-purified mouse monoclonal antibody JL-8 (Clontech) for AcGFP, mouse
monoclonal anti-human Ago2 antibody (Wako), rabbit Ago2 antibody from Millipore and Cell Signaling, and mouse monoclonal anti-
actin antibody (Millipore), normal mouse and rabbit Igg (Millipore). Peroxidase-conjugated AffiniPure goat anti-mouse IgG (Jackson
ImmunoResearch Laboratories) was used as secondary antibody for western blots. The antibodies used for immunocytochemistry
were prolactin antibody (Thermo Fisher) as the primary, and Rhodamine (TRITC)-conjugated AffiniPure goat anti-mouse IgG as the
secondary antibody (Jackson ImmunoResearch Laboratories).
Cell Culture, Transfections, Western Blot Analysis, mRNA Stability/Degradation Experiments
Expression of WT andmutated PPLs was conducted in cultures of HeLa Tet-On (Clontech), HeLa (American Type Culture Collection,
ATCC), or HEK293 (ATCC) human cells. Cells were cultivated in Dulbecco’s Modified Eagle Medium (DMEM, Invitrogen) supple-
mented with 10% Fetal Calf Serum (Gemini Bio-Products), 50 U of penicillin and 50 mg of streptomycin (Invitrogen) at 37!C with
5% CO2. Plasmid transfections were conducted with Lipofectamine 2000 (Invitrogen). When indicated, the cells were treated with
10 mM MG132 or DMSO for 8.5 hr. In the case of recombinant Myc-Ago2 expression in human cells, the corresponding plasmid
or the pCS2-Myc vector (control) were transfected into HeLa Tet-On cells, and WT or D4L PPL plasmids were transfected the
next day. For western blotting proteins were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE), transferred to PVDF Immobilon membranes (Millipore) and incubated with the appropriate antibody. The ECL Plus kit (GE
Healthcare) was used for detection.
HeLa Tet-Off (Clontech) cells were used inmRNA stability/degradation experiments. To that end,WT orD4L PPLswere cloned into
the pTRE2hyg vector under the inducible Tet-response element and were cotransfected with the pBI-CMV2 plasmid encoding for
AcGFP (for normalization) into HeLa Tet-Off cells. In HeLa Tet-Off cells cultured in the absence of the antibiotic, mRNA is normally
transcribed. However, the addition of doxycycline specifically inhibits mRNA synthesis from the gene controlled by the Tet-response
element. Cells were grown for 20 hr after transfection and then treated with doxycycline for 2.5, 4, and 6 hr (untreated cells were
controls). Total RNA was purified using the NucleoSpin RNA II kit (Clontech). WT or mutant PPL mRNA levels were determined by
qPCR.
Confocal Microscopy and Immunocytochemistry
HeLa Tet-On cells were grown on glass coverslips, transfected with WT and D4L PPLs expressing plasmids, and grown for 48 hr.
Cells were fixed with 4% (v/v) paraformaldehyde and permeabilized with 0.2% (v/v) Triton X-100 for 10 min. After a 1 hr treatment
at room temperature with blocking buffer containing 5% goat serum, 1.5% BSA, 0.1% gelatin, 0.01% sodium azide in PBS
(phosphate-buffered saline: 1 mM KH2PO4, 155 mM NaCl, 3 mM Na2HPO4, pH7.4), the cells were incubated at 4!C overnight
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ATCC), or HEK293 (ATCC) human cells. Cells were cultivated in Dulbecco’s Modified Eagle Medium (DMEM, Invitrogen) supple-
mented with 10% Fetal Calf Serum (Gemini Bio-Products), 50 U of penicillin and 50 mg of streptomycin (Invitrogen) at 37!C with
5% CO2. Plasmid transfections were conducted with Lipofectamine 2000 (Invitrogen). When indicated, the cells were treated with
10 mM MG132 or DMSO for 8.5 hr. In the case of recombinant Myc-Ago2 expression in human cells, the corresponding plasmid
or the pCS2-Myc vector (control) were transfected into HeLa Tet-On cells, and WT or D4L PPL plasmids were transfected the
next day. For western blotting proteins were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE), transferred to PVDF Immobilon membranes (Millipore) and incubated with the appropriate antibody. The ECL Plus kit (GE
Healthcare) was used for detection.
HeLa Tet-Off (Clontech) cells were used inmRNA stability/degradation experiments. To that end,WT orD4L PPLswere cloned into
the pTRE2hyg vector under the inducible Tet-response element and were cotransfected with the pBI-CMV2 plasmid encoding for
AcGFP (for normalization) into HeLa Tet-Off cells. In HeLa Tet-Off cells cultured in the absence of the antibiotic, mRNA is normally
transcribed. However, the addition of doxycycline specifically inhibits mRNA synthesis from the gene controlled by the Tet-response
element. Cells were grown for 20 hr after transfection and then treated with doxycycline for 2.5, 4, and 6 hr (untreated cells were
controls). Total RNA was purified using the NucleoSpin RNA II kit (Clontech). WT or mutant PPL mRNA levels were determined by
qPCR.
Confocal Microscopy and Immunocytochemistry
HeLa Tet-On cells were grown on glass coverslips, transfected with WT and D4L PPLs expressing plasmids, and grown for 48 hr.
Cells were fixed with 4% (v/v) paraformaldehyde and permeabilized with 0.2% (v/v) Triton X-100 for 10 min. After a 1 hr treatment
at room temperature with blocking buffer containing 5% goat serum, 1.5% BSA, 0.1% gelatin, 0.01% sodium azide in PBS
(phosphate-buffered saline: 1 mM KH2PO4, 155 mM NaCl, 3 mM Na2HPO4, pH7.4), the cells were incubated at 4!C overnight
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with prolactin antibody, washed with PBS, then incubated with secondary antibodies at room temperature for 1 hr, and washed with
PBS. Confocal images were taken with the Bio-Rad MCR-1000 Laser Scanning Confocal Imaging System.
Pulse-Labeling Experiments
HeLa Tet-On cells were transfected with WT or D4L PPL plasmids as above. Twenty hours after transfection, cells were starved for
40 min in DMEM media without methionine/cysteine (Invitrogen) supplemented with 1 mM glutamine in the presence or absence of
20 mMMG132. Efficient inhibition of the proteasome by MG132 was confirmed by monitoring the fluorogenic peptide (Succinyl-Leu-
Leu-Val-Tyr-7-amino-4-methylcoumarin, Bachem) (Kaneko et al., 2009) and by testing inhibition of proteasome in vivo by using a
known proteasome substrate SOD1 fusion protein expressed in human cultured cells (Somalinga et al., 2011). Cells were labeled
with EasyTag EXPRESS 35S Protein Labeling Mix (100 mCi/ml, Perkin Elmer). At the 0, 2, 5, 15, and 30min of labeling, media and cells
were collected. Cells were lysed in RIPA buffer (20mMTris-HCl (pH 7.6), 150mMNaCl, 0.1% (w/v) SDS, 1% (v/v) IGEPAL, 0.5% (w/v)
deoxycholic acid, complete protease inhibitor cocktail [Roche]) on ice for one hour, and lysates were cleared by centrifugation
(13,000 g, 30 min, 4!C). Separate aliquots of the samples were used either for immunoprecipitation of PPL or for SDS-PAGE analysis
followed by western blotting to detect AcGFP. For immunoprecipitation, the cell lysates were incubated with prolactin antibody
overnight at 4!C, then 40 ml of protein G-Sepharose (Calbiochem) were added, and incubation was continued for 4 hr. Beads
were collected by centrifugation, washed 3 times with RIPA buffer, and samples were analyzed by SDS-PAGE. Gels were visualized
on a Typhoon 9410 Variable Mode Imager (GE Healthcare). The presence of labeled PPL in the media was also examined by immu-
noprecipitation, and was found to be below the detection limit at the time points of the experiment. Quantification was performed
using the Quantity One Software (Bio-Rad). Each preprolactin sample was normalized to its AcGFP content. The amount of radio-
labeled PPL was calculated relative to WT PPL after 15 min of labeling without MG132.
RNA Interference Experiments
siRNAs were synthesized by Dharmacon. HeLa Tet-On cells were transfected with siRNAs using Lipofectamine RNAiMAX
(Invitrogen), followed by transfection with WT or mutant PPL plasmids the next or second day after siRNA transfection. In the exper-
iment with endogenous Ago2 knockdown and expression of recombinant WT Ago2 or D597Amutant, the cells were first treated with
endogenous Ago2 specific siRNAs (target 30-UTR of endogenous Ago2, a sequence absent in the recombinant Ago2), Ago2 expres-
sion plasmids were transfected the next day, and PPL expression plasmids were transfected a day later. Cells were incubated for
42 hr after PPL transfections. The following siRNAs were used for knock down of SRP54 (sense: GAAAUGAACAGGAGUCAAUdTdT)
(Ren et al., 2004), Ago1 (GCACAGUAUUUCAAGCAGA, CAACGAACGGGUCGACUUU), Ago3 (UCAUGUAACUGGACGCGUA, AGA
GAACAGUAGCGCAGUA), Ago4 (GUGGACAGAUGAAACGAAA, CAAUAUGGAGGCCGGAAUA), TNRC6A (GCCUAAAUAUUGGU
GAUUA, CCGGUUCAGUGCAGAAUAA), TNRC6B (GCACUGCCCUGAUCCGAUA, GGAGUGCCAUGGAAAGGUA), TNRC6C
(CUAUUAACCUCGCCAAUUA, GAAUUCUUCUAGACAGAUA), Dicer (UAAAGUAGCUGGAAUGAUG, GAAUAUGGUUGUUU
GAAGA), Drosha (GGCCAACUGUUAUAGAAUA, GGCCAACUGUUAUAGAAUA), SRa (GCGAGGAGUUCAUUCAGAA, GAGCUU
GAGUCGUGAAGAC), SRb (UUAGAGCGGUUUAAGUCUU, CAUGAGAGUUUGAGGCUUC), Sec61a (ACUUUGAGAUCUUC
GUUAA, GUGUCAUCCUGCCGGAAAU), for Ago2 knockdown Ago2-specific siRNAs were as published (Chu et al., 2010). Silencer
Negative Control #1 siRNA (Ambion) or control siRNA (ACUACAUCGUGAUUCAAACUU) were used as controls.
cDNAs, Quantitative Real Time-PCR
Total RNAwas purified using the NucleoSpin RNA II kit (Clontech) or Trizol (Ambion). cDNAs were synthesized using a High-Capacity
cDNA reverse transcription kit (Applied Biosystems). qPCR was conducted using Power SYBR Green and the 7900HT Fast Real-
Time PCR System (Applied Biosystems). PPLs, both WT and mutants, were detected by 1857-1858 or 1852-1877 primer sets (Table
S3). The PPL WT-specific primer set was 1932-1934, and the PPL D4L mutant-specific primer set was 1933-1934. The following
primers were used to detect expression of SRP54 (1880-1881), AcGFP (1913-1914), actin (1896-1897), CA4 (4426; RTPrimerDB
ID 4426), AT (2157-2158), alkaline phosphatase (1981-1982), Bip (1987-1988), calreticulin (1989-1990), SRa (2121-2122), SRb
(2238-2239), HPRT (1894-1895), PK (2281-2282, primers specific to cloned PK only), Luc (2148-2149), Ago1 (2226-2227), Ago3
(2228-2229), Ago4 (2230-2231), TNRC6A (2046-2047), TNRC6B (2300-2301), TNRC6C (2234-2235), Dicer (Dicer F- Dicer R), Drosha
(2236-2237), Sec61a (2240-2241), HMGA2 (2312-2313). let-7b, miR-22 and U6 snRNAwere analyzed by TaqManMicroRNA Assays
(Applied Biosystems), qPCR data were analyzed by the comparative CT method (Schmittgen and Livak, 2008).
Northern Blot
RNA probes for northern blots were generated by in vitro transcription using SP6 RNA polymerase (New England Biolabs) from PCR
templates. The SP6 promoter sequence was introduced into a primer, and the primer sets were designed to generate antisense RNA
probes. The 2001-2002 set was used to generate the PPL-specific probe, while the 2003-2004 set generated the AcGFP-specific
probe. A plasmid carrying PPL and the pBI-CMV2 plasmid carrying AcGFPwere used as PCR templates tomake probes. To produce
an actin control probe, total RNA was purified from HeLa Tet-On cells, and actin cDNA was produced using SuperScript II Reverse
Transcriptase (Invitrogen). The cDNA was amplified by PCR with 2009-2010 primers. The product of the first PCR reaction served as
a template for a second PCR reaction with primers 2011-2012. Finally, an antisense actin RNA probewas synthesized using SP6RNA
polymerase. RNA probes for hybridization were purified via the NucleoSpin RNA II kit (Clontech), and labeled using the BrightStar
S2 Cell 156, 146–157, January 16, 2014 ª2014 Elsevier Inc.
with prolactin antibody, washed with PBS, then incubated with secondary antibodies at room temperature for 1 hr, and washed with
PBS. Confocal images were taken with the Bio-Rad MCR-1000 Laser Scanning Confocal Imaging System.
Pulse-Labeling Experiments
HeLa Tet-On cells were transfected with WT or D4L PPL plasmids as above. Twenty hours after transfection, cells were starved for
40 min in DMEM media without methionine/cysteine (Invitrogen) supplemented with 1 mM glutamine in the presence or absence of
20 mMMG132. Efficient inhibition of the proteasome by MG132 was confirmed by monitoring the fluorogenic peptide (Succinyl-Leu-
Leu-Val-Tyr-7-amino-4-methylcoumarin, Bachem) (Kaneko et al., 2009) and by testing inhibition of proteasome in vivo by using a
known proteasome substrate SOD1 fusion protein expressed in human cultured cells (Somalinga et al., 2011). Cells were labeled
with EasyTag EXPRESS 35S Protein Labeling Mix (100 mCi/ml, Perkin Elmer). At the 0, 2, 5, 15, and 30min of labeling, media and cells
were collected. Cells were lysed in RIPA buffer (20mMTris-HCl (pH 7.6), 150mMNaCl, 0.1% (w/v) SDS, 1% (v/v) IGEPAL, 0.5% (w/v)
deoxycholic acid, complete protease inhibitor cocktail [Roche]) on ice for one hour, and lysates were cleared by centrifugation
(13,000 g, 30 min, 4!C). Separate aliquots of the samples were used either for immunoprecipitation of PPL or for SDS-PAGE analysis
followed by western blotting to detect AcGFP. For immunoprecipitation, the cell lysates were incubated with prolactin antibody
overnight at 4!C, then 40 ml of protein G-Sepharose (Calbiochem) were added, and incubation was continued for 4 hr. Beads
were collected by centrifugation, washed 3 times with RIPA buffer, and samples were analyzed by SDS-PAGE. Gels were visualized
on a Typhoon 9410 Variable Mode Imager (GE Healthcare). The presence of labeled PPL in the media was also examined by immu-
noprecipitation, and was found to be below the detection limit at the time points of the experiment. Quantification was performed
using the Quantity One Software (Bio-Rad). Each preprolactin sample was normalized to its AcGFP content. The amount of radio-
labeled PPL was calculated relative to WT PPL after 15 min of labeling without MG132.
RNA Interference Experiments
siRNAs were synthesized by Dharmacon. HeLa Tet-On cells were transfected with siRNAs using Lipofectamine RNAiMAX
(Invitrogen), followed by transfection with WT or mutant PPL plasmids the next or second day after siRNA transfection. In the exper-
iment with endogenous Ago2 knockdown and expression of recombinant WT Ago2 or D597Amutant, the cells were first treated with
endogenous Ago2 specific siRNAs (target 30-UTR of endogenous Ago2, a sequence absent in the recombinant Ago2), Ago2 expres-
sion plasmids were transfected the next day, and PPL expression plasmids were transfected a day later. Cells were incubated for
42 hr after PPL transfections. The following siRNAs were used for knock down of SRP54 (sense: GAAAUGAACAGGAGUCAAUdTdT)
(Ren et al., 2004), Ago1 (GCACAGUAUUUCAAGCAGA, CAACGAACGGGUCGACUUU), Ago3 (UCAUGUAACUGGACGCGUA, AGA
GAACAGUAGCGCAGUA), Ago4 (GUGGACAGAUGAAACGAAA, CAAUAUGGAGGCCGGAAUA), TNRC6A (GCCUAAAUAUUGGU
GAUUA, CCGGUUCAGUGCAGAAUAA), TNRC6B (GCACUGCCCUGAUCCGAUA, GGAGUGCCAUGGAAAGGUA), TNRC6C
(CUAUUAACCUCGCCAAUUA, GAAUUCUUCUAGACAGAUA), Dicer (UAAAGUAGCUGGAAUGAUG, GAAUAUGGUUGUUU
GAAGA), Drosha (GGCCAACUGUUAUAGAAUA, GGCCAACUGUUAUAGAAUA), SRa (GCGAGGAGUUCAUUCAGAA, GAGCUU
GAGUCGUGAAGAC), SRb (UUAGAGCGGUUUAAGUCUU, CAUGAGAGUUUGAGGCUUC), Sec61a (ACUUUGAGAUCUUC
GUUAA, GUGUCAUCCUGCCGGAAAU), for Ago2 knockdown Ago2-specific siRNAs were as published (Chu et al., 2010). Silencer
Negative Control #1 siRNA (Ambion) or control siRNA (ACUACAUCGUGAUUCAAACUU) were used as controls.
cDNAs, Quantitative Real Time-PCR
Total RNAwas purified using the NucleoSpin RNA II kit (Clontech) or Trizol (Ambion). cDNAs were synthesized using a High-Capacity
cDNA reverse transcription kit (Applied Biosystems). qPCR was conducted using Power SYBR Green and the 7900HT Fast Real-
Time PCR System (Applied Biosystems). PPLs, both WT and mutants, were detected by 1857-1858 or 1852-1877 primer sets (Table
S3). The PPL WT-specific primer set was 1932-1934, and the PPL D4L mutant-specific primer set was 1933-1934. The following
primers were used to detect expression of SRP54 (1880-1881), AcGFP (1913-1914), actin (1896-1897), CA4 (4426; RTPrimerDB
ID 4426), AT (2157-2158), alkaline phosphatase (1981-1982), Bip (1987-1988), calreticulin (1989-1990), SRa (2121-2122), SRb
(2238-2239), HPRT (1894-1895), PK (2281-2282, primers specific to cloned PK only), Luc (2148-2149), Ago1 (2226-2227), Ago3
(2228-2229), Ago4 (2230-2231), TNRC6A (2046-2047), TNRC6B (2300-2301), TNRC6C (2234-2235), Dicer (Dicer F- Dicer R), Drosha
(2236-2237), Sec61a (2240-2241), HMGA2 (2312-2313). let-7b, miR-22 and U6 snRNAwere analyzed by TaqManMicroRNA Assays
(Applied Biosystems), qPCR data were analyzed by the comparative CT method (Schmittgen and Livak, 2008).
Northern Blot
RNA probes for northern blots were generated by in vitro transcription using SP6 RNA polymerase (New England Biolabs) from PCR
templates. The SP6 promoter sequence was introduced into a primer, and the primer sets were designed to generate antisense RNA
probes. The 2001-2002 set was used to generate the PPL-specific probe, while the 2003-2004 set generated the AcGFP-specific
probe. A plasmid carrying PPL and the pBI-CMV2 plasmid carrying AcGFPwere used as PCR templates tomake probes. To produce
an actin control probe, total RNA was purified from HeLa Tet-On cells, and actin cDNA was produced using SuperScript II Reverse
Transcriptase (Invitrogen). The cDNA was amplified by PCR with 2009-2010 primers. The product of the first PCR reaction served as
a template for a second PCR reaction with primers 2011-2012. Finally, an antisense actin RNA probewas synthesized using SP6RNA
polymerase. RNA probes for hybridization were purified via the NucleoSpin RNA II kit (Clontech), and labeled using the BrightStar
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with prolactin antibody, washed with PBS, then incubated with secondary antibodies at room temperature for 1 hr, and washed with
PBS. Confocal images were taken with the Bio-Rad MCR-1000 Laser Scanning Confocal Imaging System.
Pulse-Labeling Experiments
HeLa Tet-On cells were transfected with WT or D4L PPL plasmids as above. Twenty hours after transfection, cells were starved for
40 min in DMEM media without methionine/cysteine (Invitrogen) supplemented with 1 mM glutamine in the presence or absence of
20 mMMG132. Efficient inhibition of the proteasome by MG132 was confirmed by monitoring the fluorogenic peptide (Succinyl-Leu-
Leu-Val-Tyr-7-amino-4-methylcoumarin, Bachem) (Kaneko et al., 2009) and by testing inhibition of proteasome in vivo by using a
known proteasome substrate SOD1 fusion protein expressed in human cultured cells (Somalinga et al., 2011). Cells were labeled
with EasyTag EXPRESS 35S Protein Labeling Mix (100 mCi/ml, Perkin Elmer). At the 0, 2, 5, 15, and 30min of labeling, media and cells
were collected. Cells were lysed in RIPA buffer (20mMTris-HCl (pH 7.6), 150mMNaCl, 0.1% (w/v) SDS, 1% (v/v) IGEPAL, 0.5% (w/v)
deoxycholic acid, complete protease inhibitor cocktail [Roche]) on ice for one hour, and lysates were cleared by centrifugation
(13,000 g, 30 min, 4!C). Separate aliquots of the samples were used either for immunoprecipitation of PPL or for SDS-PAGE analysis
followed by western blotting to detect AcGFP. For immunoprecipitation, the cell lysates were incubated with prolactin antibody
overnight at 4!C, then 40 ml of protein G-Sepharose (Calbiochem) were added, and incubation was continued for 4 hr. Beads
were collected by centrifugation, washed 3 times with RIPA buffer, and samples were analyzed by SDS-PAGE. Gels were visualized
on a Typhoon 9410 Variable Mode Imager (GE Healthcare). The presence of labeled PPL in the media was also examined by immu-
noprecipitation, and was found to be below the detection limit at the time points of the experiment. Quantification was performed
using the Quantity One Software (Bio-Rad). Each preprolactin sample was normalized to its AcGFP content. The amount of radio-
labeled PPL was calculated relative to WT PPL after 15 min of labeling without MG132.
RNA Interference Experiments
siRNAs were synthesized by Dharmacon. HeLa Tet-On cells were transfected with siRNAs using Lipofectamine RNAiMAX
(Invitrogen), followed by transfection with WT or mutant PPL plasmids the next or second day after siRNA transfection. In the exper-
iment with endogenous Ago2 knockdown and expression of recombinant WT Ago2 or D597Amutant, the cells were first treated with
endogenous Ago2 specific siRNAs (target 30-UTR of endogenous Ago2, a sequence absent in the recombinant Ago2), Ago2 expres-
sion plasmids were transfected the next day, and PPL expression plasmids were transfected a day later. Cells were incubated for
42 hr after PPL transfections. The following siRNAs were used for knock down of SRP54 (sense: GAAAUGAACAGGAGUCAAUdTdT)
(Ren et al., 2004), Ago1 (GCACAGUAUUUCAAGCAGA, CAACGAACGGGUCGACUUU), Ago3 (UCAUGUAACUGGACGCGUA, AGA
GAACAGUAGCGCAGUA), Ago4 (GUGGACAGAUGAAACGAAA, CAAUAUGGAGGCCGGAAUA), TNRC6A (GCCUAAAUAUUGGU
GAUUA, CCGGUUCAGUGCAGAAUAA), TNRC6B (GCACUGCCCUGAUCCGAUA, GGAGUGCCAUGGAAAGGUA), TNRC6C
(CUAUUAACCUCGCCAAUUA, GAAUUCUUCUAGACAGAUA), Dicer (UAAAGUAGCUGGAAUGAUG, GAAUAUGGUUGUUU
GAAGA), Drosha (GGCCAACUGUUAUAGAAUA, GGCCAACUGUUAUAGAAUA), SRa (GCGAGGAGUUCAUUCAGAA, GAGCUU
GAGUCGUGAAGAC), SRb (UUAGAGCGGUUUAAGUCUU, CAUGAGAGUUUGAGGCUUC), Sec61a (ACUUUGAGAUCUUC
GUUAA, GUGUCAUCCUGCCGGAAAU), for Ago2 knockdown Ago2-specific siRNAs were as published (Chu et al., 2010). Silencer
Negative Control #1 siRNA (Ambion) or control siRNA (ACUACAUCGUGAUUCAAACUU) were used as controls.
cDNAs, Quantitative Real Time-PCR
Total RNAwas purified using the NucleoSpin RNA II kit (Clontech) or Trizol (Ambion). cDNAs were synthesized using a High-Capacity
cDNA reverse transcription kit (Applied Biosystems). qPCR was conducted using Power SYBR Green and the 7900HT Fast Real-
Time PCR System (Applied Biosystems). PPLs, both WT and mutants, were detected by 1857-1858 or 1852-1877 primer sets (Table
S3). The PPL WT-specific primer set was 1932-1934, and the PPL D4L mutant-specific primer set was 1933-1934. The following
primers were used to detect expression of SRP54 (1880-1881), AcGFP (1913-1914), actin (1896-1897), CA4 (4426; RTPrimerDB
ID 4426), AT (2157-2158), alkaline phosphatase (1981-1982), Bip (1987-1988), calreticulin (1989-1990), SRa (2121-2122), SRb
(2238-2239), HPRT (1894-1895), PK (2281-2282, primers specific to cloned PK only), Luc (2148-2149), Ago1 (2226-2227), Ago3
(2228-2229), Ago4 (2230-2231), TNRC6A (2046-2047), TNRC6B (2300-2301), TNRC6C (2234-2235), Dicer (Dicer F- Dicer R), Drosha
(2236-2237), Sec61a (2240-2241), HMGA2 (2312-2313). let-7b, miR-22 and U6 snRNAwere analyzed by TaqManMicroRNA Assays
(Applied Biosystems), qPCR data were analyzed by the comparative CT method (Schmittgen and Livak, 2008).
Northern Blot
RNA probes for northern blots were generated by in vitro transcription using SP6 RNA polymerase (New England Biolabs) from PCR
templates. The SP6 promoter sequence was introduced into a primer, and the primer sets were designed to generate antisense RNA
probes. The 2001-2002 set was used to generate the PPL-specific probe, while the 2003-2004 set generated the AcGFP-specific
probe. A plasmid carrying PPL and the pBI-CMV2 plasmid carrying AcGFPwere used as PCR templates tomake probes. To produce
an actin control probe, total RNA was purified from HeLa Tet-On cells, and actin cDNA was produced using SuperScript II Reverse
Transcriptase (Invitrogen). The cDNA was amplified by PCR with 2009-2010 primers. The product of the first PCR reaction served as
a template for a second PCR reaction with primers 2011-2012. Finally, an antisense actin RNA probewas synthesized using SP6RNA
polymerase. RNA probes for hybridization were purified via the NucleoSpin RNA II kit (Clontech), and labeled using the BrightStar
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Psoralen-Biotin Nonisotopic Labeling Kit (Ambion). Total RNAswere purified from cultured human cells and separated by agarose gel
electrophoresis in the presence of formaldehyde before being transferred to BrightStar-Plus positively charged nylon membranes
(Ambion) using Model 785 Vacuum Blotter (Bio-Rad). The RNA on the membranes were detected by hybridization with the
above probes in ULTRAhyb buffer and detected by BrightStar BioDetect Kit (Ambion) according to the manufacturer’s instructions.
Northern blots were quantified by ImageJ software (NIH); PPL mRNA levels were calculated relatively to PPL WT with a control
transfection.
RNA Immunoprecipitation
HeLa Tet-On cells transfected either with WT PPL or D4L expression plasmids were grown for 24 hr after transfection and lysed in
buffer containing 20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.5% NP-40, 1 mM EDTA, 1 mM DTT, RNAsin (Promega) and protease
inhibitors (Roche). Endogenous Ago2 was immunoprecipated from cell lysates with an Ago2 mouse monoclonal antibody (Wako)
and Protein G-Agarose (Roche) according manufacturer’s recommendations. Beads incubated with normal mouse IgG (Millipore)
served as a negative control. After incubation for 4 hr, beads were washed several times using cell lysis buffer. RNA/protein com-
plexes were eluted from the beads using buffer containing 10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 1% SDS and divided into two
aliquots used either for western blotting or RNA extraction. RNA was extracted using Trizol LS reagent (Invitrogen), treated with
DNase and used for cDNA production and subsequent semiquantitative RT–PCR (Karamysheva et al., 2003) or qPCR reactions.
Ago2 was detected in immunoprecipitates by western blot using Ago2 rabbit antibodies from Cell Signaling. A similar RNA immuno-
precipitation experiment was performed using rabbit polyclonal Ago2 antibody (Millipore) and normal rabbit IgG (Millipore) as a nega-
tive control. Ago2 was detected in immunoprecipitates by western blot using Ago2 mouse monoclonal antibodies (Wako). Data
analyzed by the fold enrichment method (Ciccone et al., 2004).
Canine SRP, ER Microsomes, Ago2 Purification
Canine SRP was purified as described previously (Walter and Blobel, 1983b), except that the sucrose density sedimentation was
omitted. Canine endoplasmic reticulum rough microsomes (ER microsomes or RMs) were prepared as before (Walter and Blobel,
1983a). Expression and purification of recombinant human Ago2 was described previously (Ye et al., 2011).
In Vitro Translation and Photocrosslinking
Translations (30 min, 30!C) of full-length mRNA were performed in a total volume of 10 ml containing nuclease-treated reticulocyte
lysate, 0.8 ml EGS-M [15 mM ATP, 15 mM GTP, 120 mM phosphocreatine, 0.12 U/ml creatine phosphokinase, 0.375 mM of each
amino acid except methionine in 90 mM HEPES (pH 7.5)], 50 mg/ml bovine tRNA, 2.5 mM magnesium acetate (MgAcetate),
70 mM potassium acetate, 0.8 U/ml RNasin, 0.35 mCi/ml [35S]methionine, 0.8 equivalents of ER microsomes (RMs). Translated pro-
teins were separated by 12% SDS-PAGE and visualized by phosphoimager.
For photocrosslinking experiments, in vitro translations (25 ml total volume; 26!C, 30-40min in the dark) contained wheat germ cell-
free extract (Erickson and Blobel, 1983), 25 mCi of [35S]methionine, 25-35 pmole of εANB-Lys-tRNAamb or unmodified Lys-tRNAamb,
the desired truncated mRNA, 60 nM canine SRP (Walter and Blobel, 1983b) where indicated, and other components as described
previously (Do et al., 1996; McCormick et al., 2003). After photolysis (Do et al., 1996), ribosomes were pelleted, resuspended and
treatedwith RNase A and EDTA (Etchells et al., 2005), and analyzed by 10%–15%gradient SDS-PAGE. Photoadducts were detected
by phosphorimager. The quantity of each photoadduct was normalized to the total amount of the corresponding nascent chain, and
then compared to the WT PPL crosslink normalized in the same manner.
For immunoprecipitation of nascent chain photoadducts to SRP54, ribosome pellets from photolyzed 50-ml translations were
resuspended in 55 ml of 0.25% (w/v) SDS, 100 mM Tris-HCl (pH 7.5) and placed at 55!C for 30 min. After 5 ml were removed for direct
analysis by SDS-PAGE, the remaining 50 ml were supplemented with 500 ml immunoprecipitation buffer [140 mM NaCl, 10 mM
Tris-HCl (pH 7.5), 2% (v/v) Triton X-100], followed by 2.5 ml SRP54-specific antibody. After overnight shaking at 4!C, 40 ml of protein
G-Sepharose (Calbiochem) were added and incubated for 2 hr. Beads were recovered by centrifugation, washed twice with immu-
noprecipitation buffer and one timewith immunoprecipitation buffer lacking Triton X-100. Samples were analyzed by SDS-PAGE and
visualized as above.
Photocrosslinking Assay for the Identification of Proteins Interacting with Mutant Nascent PPL
Fractions of cell lysates were tested for the presence of proteins forming a photoadduct with mutant PPL. For this purpose
salt-washed ribosome nascent chain complexes (salt-washed RNCs) of mutated D4L PPL-86 truncated mRNA were prepared.
Translations were conducted in the dark for 40 min as above, except that reactions were conducted in a total volume of 225–
500 ml. At the end of translation, KAcetate was added to 300–400mMand samples were incubated on ice for 10–15min. Salt-washed
RNCs were collected by centrifugation through sucrose cushions as above, except that the sucrose cushions contained 300 mM
KAcetate. Pellets were resuspended in buffer (50 mM HEPES [pH 7.5], 40 mM KAcetate, 5 mM MgCl2), aliquoted, and combined
with fractionated proteins or purified Ago2. After incubation on ice for 15 min, samples were photolyzed and analyzed by SDS-
PAGE as above.
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Psoralen-Biotin Nonisotopic Labeling Kit (Ambion). Total RNAswere purified from cultured human cells and separated by agarose gel
electrophoresis in the presence of formaldehyde before being transferred to BrightStar-Plus positively charged nylon membranes
(Ambion) using Model 785 Vacuum Blotter (Bio-Rad). The RNA on the membranes were detected by hybridization with the
above probes in ULTRAhyb buffer and detected by BrightStar BioDetect Kit (Ambion) according to the manufacturer’s instructions.
Northern blots were quantified by ImageJ software (NIH); PPL mRNA levels were calculated relatively to PPL WT with a control
transfection.
RNA Immunoprecipitation
HeLa Tet-On cells transfected either with WT PPL or D4L expression plasmids were grown for 24 hr after transfection and lysed in
buffer containing 20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.5% NP-40, 1 mM EDTA, 1 mM DTT, RNAsin (Promega) and protease
inhibitors (Roche). Endogenous Ago2 was immunoprecipated from cell lysates with an Ago2 mouse monoclonal antibody (Wako)
and Protein G-Agarose (Roche) according manufacturer’s recommendations. Beads incubated with normal mouse IgG (Millipore)
served as a negative control. After incubation for 4 hr, beads were washed several times using cell lysis buffer. RNA/protein com-
plexes were eluted from the beads using buffer containing 10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 1% SDS and divided into two
aliquots used either for western blotting or RNA extraction. RNA was extracted using Trizol LS reagent (Invitrogen), treated with
DNase and used for cDNA production and subsequent semiquantitative RT–PCR (Karamysheva et al., 2003) or qPCR reactions.
Ago2 was detected in immunoprecipitates by western blot using Ago2 rabbit antibodies from Cell Signaling. A similar RNA immuno-
precipitation experiment was performed using rabbit polyclonal Ago2 antibody (Millipore) and normal rabbit IgG (Millipore) as a nega-
tive control. Ago2 was detected in immunoprecipitates by western blot using Ago2 mouse monoclonal antibodies (Wako). Data
analyzed by the fold enrichment method (Ciccone et al., 2004).
Canine SRP, ER Microsomes, Ago2 Purification
Canine SRP was purified as described previously (Walter and Blobel, 1983b), except that the sucrose density sedimentation was
omitted. Canine endoplasmic reticulum rough microsomes (ER microsomes or RMs) were prepared as before (Walter and Blobel,
1983a). Expression and purification of recombinant human Ago2 was described previously (Ye et al., 2011).
In Vitro Translation and Photocrosslinking
Translations (30 min, 30!C) of full-length mRNA were performed in a total volume of 10 ml containing nuclease-treated reticulocyte
lysate, 0.8 ml EGS-M [15 mM ATP, 15 mM GTP, 120 mM phosphocreatine, 0.12 U/ml creatine phosphokinase, 0.375 mM of each
amino acid except methionine in 90 mM HEPES (pH 7.5)], 50 mg/ml bovine tRNA, 2.5 mM magnesium acetate (MgAcetate),
70 mM potassium acetate, 0.8 U/ml RNasin, 0.35 mCi/ml [35S]methionine, 0.8 equivalents of ER microsomes (RMs). Translated pro-
teins were separated by 12% SDS-PAGE and visualized by phosphoimager.
For photocrosslinking experiments, in vitro translations (25 ml total volume; 26!C, 30-40min in the dark) contained wheat germ cell-
free extract (Erickson and Blobel, 1983), 25 mCi of [35S]methionine, 25-35 pmole of εANB-Lys-tRNAamb or unmodified Lys-tRNAamb,
the desired truncated mRNA, 60 nM canine SRP (Walter and Blobel, 1983b) where indicated, and other components as described
previously (Do et al., 1996; McCormick et al., 2003). After photolysis (Do et al., 1996), ribosomes were pelleted, resuspended and
treatedwith RNase A and EDTA (Etchells et al., 2005), and analyzed by 10%–15%gradient SDS-PAGE. Photoadducts were detected
by phosphorimager. The quantity of each photoadduct was normalized to the total amount of the corresponding nascent chain, and
then compared to the WT PPL crosslink normalized in the same manner.
For immunoprecipitation of nascent chain photoadducts to SRP54, ribosome pellets from photolyzed 50-ml translations were
resuspended in 55 ml of 0.25% (w/v) SDS, 100 mM Tris-HCl (pH 7.5) and placed at 55!C for 30 min. After 5 ml were removed for direct
analysis by SDS-PAGE, the remaining 50 ml were supplemented with 500 ml immunoprecipitation buffer [140 mM NaCl, 10 mM
Tris-HCl (pH 7.5), 2% (v/v) Triton X-100], followed by 2.5 ml SRP54-specific antibody. After overnight shaking at 4!C, 40 ml of protein
G-Sepharose (Calbiochem) were added and incubated for 2 hr. Beads were recovered by centrifugation, washed twice with immu-
noprecipitation buffer and one timewith immunoprecipitation buffer lacking Triton X-100. Samples were analyzed by SDS-PAGE and
visualized as above.
Photocrosslinking Assay for the Identification of Proteins Interacting with Mutant Nascent PPL
Fractions of cell lysates were tested for the presence of proteins forming a photoadduct with mutant PPL. For this purpose
salt-washed ribosome nascent chain complexes (salt-washed RNCs) of mutated D4L PPL-86 truncated mRNA were prepared.
Translations were conducted in the dark for 40 min as above, except that reactions were conducted in a total volume of 225–
500 ml. At the end of translation, KAcetate was added to 300–400mMand samples were incubated on ice for 10–15min. Salt-washed
RNCs were collected by centrifugation through sucrose cushions as above, except that the sucrose cushions contained 300 mM
KAcetate. Pellets were resuspended in buffer (50 mM HEPES [pH 7.5], 40 mM KAcetate, 5 mM MgCl2), aliquoted, and combined
with fractionated proteins or purified Ago2. After incubation on ice for 15 min, samples were photolyzed and analyzed by SDS-
PAGE as above.
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Northern blots were quantified by ImageJ software (NIH); PPL mRNA levels were calculated relatively to PPL WT with a control
transfection.
I r cipitation
t- lls transfected either with WT P L or D4L expression plasmids wer grown for 24 hr after transfection a d lysed in
ff r t i i 20 Tris-HCl, pH 7.5, 150 mM NaCl, 0.5% NP-40, 1 mM EDTA, 1 mM DTT, RNAsin (Promega) nd protease
i i it r ( e). Endogenous Ago2 was immunoprecipated from cell lysates with an Ago2 mouse mon cl nal ntibody (Wako)
t i - garose (Roche) ac ording manufacturer’s recom endations. Beads incubated with normal mouse IgG (Millipore)
ative control. After incubation for 4 hr, beads wer washed several times using cell lysis buffer. RNA/protein com-
r l ted fro the beads using buffer containi g 10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 1% SDS and divide into two
ither for western blot ing or RNA extraction. RNA was extracted using Trizol LS reagent (Invitrogen), treat d with
for cDNA production and subsequent semiquantitative RT–PCR (Kar mysheva et al., 2003) or qPCR reactions.
t ted in i unoprecipitates by western blot using Ago2 rab it antibodies from Cell Signaling. A similar RNA immuno-
i i ti eri ent was performed using rab it polyclonal Ago2 antibody (Millipore) and normal rabbit IgG (Millipore) as nega-
ti tr l. 2 as detected in immunoprecipitates by western blot using Ago2 mouse mon clonal ntibodies (Wako). Data
l t fold enrichment method (Cic one et al., 20 4).
anine S , icrosomes, Ago2 Purification
Canine SRP was purified as described previously (Walter and Blobel, 1983b), except that the sucrose density sedimentation was
o itted. Canine endoplasmic reticulum rough microsomes (ER microsomes or RMs) were prepared as before (Walter and Blobel,
1983a). Expression and purification of recombinant human Ago2 was described previously (Ye et al., 2011).
In Vitro Translation and Photocrosslinking
Translations (30 min, 30!C) of full-length mRNA were performed in a total volume of 10 ml containing nuclease-treated reticulocyte
lysate, 0.8 ml EGS-M [15 mM ATP, 15 mM GTP, 120 mM phosphocreatine, 0.12 U/ml creatine phosphokinase, 0.375 mM of each
amino acid except methionine in 90 mM HEPES (pH 7.5)], 50 mg/ml bovine tRNA, 2.5 mM magnesium acetate (MgAcetate),
70 mM potassium acetate, 0.8 U/ml RNasin, 0.35 mCi/ml [35S]methionine, 0.8 equivalents of ER microsomes (RMs). Translated pro-
teins were separated by 12% SDS-PAGE and visualized by phosphoimager.
For photocrosslinking experiments, in vitro translations (25 ml total volume; 26!C, 30-40min in the dark) contained wheat germ cell-
free extract (Erickson and Blobel, 1983), 25 mCi of [35S]methionine, 25-35 pmole of εANB-Lys-tRNAamb or unmodified Lys-tRNAamb,
the desired truncated mRNA, 60 nM canine SRP (Walter and Blobel, 1983b) where indicated, and other components as described
previously (Do et al., 1996; McCormick et al., 2003). After photolysis (Do et al., 1996), ribosomes were pelleted, resuspended and
treatedwith RNase A and EDTA (Etchells et al., 2005), and analyzed by 10%–15%gradient SDS-PAGE. Photoadducts were detected
by phosphorimager. The quantity of each photoadduct was normalized to the total amount of the corresponding nascent chain, and
then compared to the WT PPL crosslink normalized in the same manner.
For immunoprecipitation of nascent chain photoadducts to SRP54, ribosome pellets from photolyzed 50-ml translations were
resuspended in 55 ml of 0.25% (w/v) SDS, 100 mM Tris-HCl (pH 7.5) and placed at 55!C for 30 min. After 5 ml were removed for direct
analysis by SDS-PAGE, the remaining 50 ml were supplemented with 500 ml immunoprecipitation buffer [140 mM NaCl, 10 mM
Tris-HCl (pH 7.5), 2% (v/v) Triton X-100], followed by 2.5 ml SRP54-specific antibody. After overnight shaking at 4!C, 40 ml of protein
G-Sepharose (Calbiochem) were added and incubated for 2 hr. Beads were recovered by centrifugation, washed twice with immu-
noprecipitation buffer and one timewith immunoprecipitation buffer lacking Triton X-100. Samples were analyzed by SDS-PAGE and
visualized as above.
Photocrosslinking Assay for the Identification of Proteins Interacting with Mutant Nascent PPL
Fractions of cell lysates were tested for the presence of proteins forming a photoadduct with mutant PPL. For this purpose
salt-washed ribosome nascent chain complexes (salt-washed RNCs) of utated D4L PPL-86 truncated mRNA were prepared.
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Purification of the !100 kDa Protein that Is Photocrosslinked to a Mutant Nascent PPL
Two independent approaches for protein purification andmass spectrometry conducted at two different facilities resulted in the iden-
tification of Ago2 as a crosslink partner of nascent mutant PPL (Table S2). The first approach was based mainly on an earlier pub-
lished method (Otto et al., 2005). Ribosomes were isolated from 200 ml of rabbit reticulocyte lysate (Green Hectares, Oregon, WI) by
centrifugation at 200,000 g for 1.5 hr. Each of the ribosomal pellets was washed once with 10ml of buffer S1 (20 mMHEPES (pH 7.4),
5 mM MgAcetate, 1 mM dithiothreitol, 1 mM PMSF) containing 50 mM KAcetate. Ribosome-associated proteins were released by
resuspending the ribosomal pellets in S1 containing 400 mM KAcetate. High-salt washed ribosomes were separated from released
proteins by centrifugation at 200,000 g for 1.5 hr. Supernatant was diluted with 4 volumes 20 mM HEPES (pH 7.4) containing 1 mM
PMSF. The material was applied to a MonoS HR5/5 column (Amersham Pharmacia) in two identical successive runs. Bound proteins
were eluted with a 50–1,200 mM, 25-ml linear KAcetate gradient in 40 mM HEPES (pH 7.4) and 1 ml fractions were collected.
Fractions 8–10 from both MonoS runs were pooled and diluted with 3 volumes of 40 mM HEPES (pH 7.4). The material was loaded
onto a MonoQ HR5/5 column (Amersham Pharmacia). Bound proteins were eluted with a 50–1,000 mM, 18-ml linear KAcetate
gradient in 40 mM HEPES (pH 7.4). One ml fractions were collected and 5 ml of fraction 3 "18 were tested in the crosslinking assay
described above. A strong nascent chain photocrosslink to a protein of!100 kDa, was observed in three fractions (8–10), with most
in fraction 9 (Figure 5E). To identify the crosslink partner, 400 ml of fraction 9 was concentrated to a volume of 100 ml and the sample
was applied to 6%–16.5% BN-PAGE followed by a second dimension separation under denaturing conditions as described (Otto
et al., 2005). Spots from the second-dimension gel were excised and analyzed via mass spectrometry (Table S2, Experimental
Approach 1).
In the second approach, ribosomes were isolated from 20 ml of rabbit reticulocyte lysate (Green Hectares, Oregon, WI) by
centrifugation at 540,000 g (Beckman TLA100.3 rotor) for 1 hr. Ribosome-associated proteins were released by resuspending of
the ribosomal pellet in buffer containing 45 mM HEPES (pH 7.5), 4.5 mM MgAcetate, 440 mM KAcetate, 2 mM glutathione, and
then separated from salt-washed ribosomes by centrifugation as above. The supernatant was dialyzed 3 times against 25 mM
HEPES (pH 7.5), 40 mM KAcetate, 2 mM glutathione, and proteins were separated on a FPLC using a 40–1,200 mM KAcetate linear
gradient in 25 mMHEPES (pH 7.5), 2 mM glutathione with a MonoQ 5/50GL column (GE Healthcare). Aliquots (2.5 ml) of each fraction
were tested using the crosslinking assay as above. Two fractions that showed a strong crosslink to a!100 kDa protein were dialyzed
as above and used for second chromatography on a 1-ml HiTrap Heparin HP column (GE Healthcare) with a 40–1200 mM KAcetate
linear gradient in 25 mMHEPES (pH 7.5), 2 mM glutathione. The resulting fractions were tested for crosslinking, and one fraction with
a strong crosslink to a !100 kDa protein was selected. Its proteins were separated by SDS-PAGE and the !100 kDa band was
excised from the gel. Mass spectrometry was conducted by the Protein Chemistry Core Facility, UT Southwestern Medical Center.
After in-gel digestion with trypsin, the peptide mixture was subjected to nano LC/MS/MS analysis. Nano-HPLC/electrospray mass
spectrometry was performed on a ThermoFinnigan LTQ instrument, coupled with an Agilent 1100 Series HPLC system. The
separation was achieved with a 75micron i.d. C18 reverse-phase chromatography column. The resulting files were searched against
NCBI-nr protein sequence databases through the Mascot search engine (Matrix Science). The results are shown in Table S2
(Experimental Approach 2). Both applied protein identifications independently revealed Ago2 protein in the selected fractions
(Table S2).
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